Healthcare provider profile · identity verified

Rakesh Jain, MD

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry · LAKE JACKSON, TX · NPI 1124221304

Profile state: payments only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Rakesh Jain, MD received $1,457,153.62 in general payments during 2025 across 1315 reported records.

ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 14.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 26 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$1,457,153.62

1315 reported records · 24 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	Unresolved — no canonical attribution shown	$205,528.90	14.1%	181	2025
Axsome Therapeutics, Inc.	Unresolved — no canonical attribution shown	$185,588.11	12.7%	165	2025
ABBVIE INC.	Unresolved — no canonical attribution shown	$166,262.38	11.4%	166	2025
Neurocrine BioSciences, Inc.	Unresolved — no canonical attribution shown	$162,201.98	11.1%	169	2025
Alkermes, Inc.	Unresolved — no canonical attribution shown	$150,279.80	10.3%	145	2025
Teva Pharmaceuticals USA, Inc.	Unresolved — no canonical attribution shown	$121,450.48	8.3%	89	2025
E.R. Squibb & Sons, L.L.C.	Unresolved — no canonical attribution shown	$118,938.16	8.2%	98	2025
Otsuka America Pharmaceutical, Inc.	Unresolved — no canonical attribution shown	$95,620.86	6.6%	119	2025
Vanda Pharmaceuticals Inc.	Unresolved — no canonical attribution shown	$65,513.06	4.5%	66	2025
Mylan Inc.	Unresolved — no canonical attribution shown	$57,537.79	4.0%	11	2025
Supernus Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$25,479.88	1.8%	27	2025
Janssen Pharmaceuticals, Inc	Unresolved — no canonical attribution shown	$21,751.86	1.5%	21	2025
Janssen Global Services, LLC	Unresolved — no canonical attribution shown	$16,599.25	1.1%	20	2025
Otsuka Pharmaceutical Development & Commercialization, Inc.	Unresolved — no canonical attribution shown	$13,567.50	0.9%	7	2025
Tris Pharma Inc	Unresolved — no canonical attribution shown	$13,500.00	0.9%	5	2025
Eli Lilly and Company	Unresolved — no canonical attribution shown	$11,943.00	0.8%	7	2025
Tonix Medicines, Inc.	Unresolved — no canonical attribution shown	$11,477.21	0.8%	8	2025
Luye Pharma (USA) Ltd.	Unresolved — no canonical attribution shown	$8,526.83	0.6%	5	2025
Oyster Point Pharma, Inc.	Unresolved — no canonical attribution shown	$2,724.00	0.2%	1	2025
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$1,130.00	0.1%	1	2025
Janssen Scientific Affairs, LLC	Unresolved — no canonical attribution shown	$705.00	0.1%	1	2025
Almatica Pharma LLC	Unresolved — no canonical attribution shown	$500.00	0.0%	1	2025
PFIZER INC.	Unresolved — no canonical attribution shown	$190.07	0.0%	1	2025
Noven Therapeutics, LLC	Unresolved — no canonical attribution shown	$137.50	0.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$773,715.00	207
Consulting Fee	$311,877.25	83
Honoraria	$198,259.00	40
Travel and Lodging	$152,627.62	505
Food and Beverage	$20,674.75	480

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
CAPLYTA Normalized: caplyta	Drug	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$205,528.90	181	2025
Source payment records 2025-02-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $6,600.00 · Open Payments source 2025-02-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $557.45 · Open Payments source 2025-02-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $147.79 · Open Payments source 2025-02-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $3,000.00 · Open Payments source 2025-02-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $557.45 · Open Payments source 2025-02-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $147.79 · Open Payments source 2025-02-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $107.01 · Open Payments source 2025-02-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $118.72 · Open Payments source 2025-03-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $6,600.00 · Open Payments source 2025-03-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $73.00 · Open Payments source 2025-03-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $139.06 · Open Payments source 2025-03-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $244.02 · Open Payments source 2025-03-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $71.85 · Open Payments source 2025-03-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $3,000.00 · Open Payments source 2025-03-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $73.00 · Open Payments source 2025-03-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $139.06 · Open Payments source 2025-03-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $15.00 · Open Payments source 2025-03-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $20.22 · Open Payments source 2025-03-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,400.00 · Open Payments source 2025-03-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $73.00 · Open Payments source 2025-03-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $139.06 · Open Payments source 2025-03-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $54.83 · Open Payments source 2025-03-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $3,000.00 · Open Payments source 2025-03-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $73.00 · Open Payments source 2025-03-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $139.06 · Open Payments source 2025-03-05 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $17.68 · Open Payments source 2025-03-06 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4,800.00 · Open Payments source 2025-03-06 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $73.00 · Open Payments source 2025-03-06 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $139.06 · Open Payments source 2025-03-06 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $37.91 · Open Payments source 2025-03-06 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $102.85 · Open Payments source 2025-03-13 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $708.17 · Open Payments source 2025-03-13 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $124.54 · Open Payments source 2025-03-13 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $360.47 · Open Payments source 2025-03-13 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $58.20 · Open Payments source 2025-03-13 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $450.40 · Open Payments source 2025-03-14 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $124.54 · Open Payments source 2025-03-14 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $40.39 · Open Payments source 2025-03-14 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $47.51 · Open Payments source 2025-03-14 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $19.01 · Open Payments source 2025-03-14 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $18.94 · Open Payments source 2025-03-14 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $7,500.00 · Open Payments source 2025-03-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $19.01 · Open Payments source 2025-03-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $47.51 · Open Payments source 2025-03-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $7.01 · Open Payments source 2025-03-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $37.20 · Open Payments source 2025-04-29 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $3,000.00 · Open Payments source 2025-04-29 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,400.00 · Open Payments source 2025-04-29 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $6.09 · Open Payments source 2025-04-29 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $40.99 · Open Payments source 2025-04-30 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,400.00 · Open Payments source 2025-04-30 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $27.51 · Open Payments source 2025-04-30 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $70.54 · Open Payments source 2025-04-30 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $3,000.00 · Open Payments source 2025-04-30 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $185.77 · Open Payments source 2025-04-30 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $24.45 · Open Payments source 2025-04-30 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $33.01 · Open Payments source 2025-05-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $3,000.00 · Open Payments source 2025-05-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $47.12 · Open Payments source 2025-05-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $13.50 · Open Payments source 2025-05-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,400.00 · Open Payments source 2025-05-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $14.91 · Open Payments source 2025-05-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $20.30 · Open Payments source 2025-05-16 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $137.80 · Open Payments source 2025-05-30 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $8,060.00 · Open Payments source 2025-07-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $104.47 · Open Payments source 2025-07-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $445.48 · Open Payments source 2025-07-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $420.18 · Open Payments source 2025-07-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $506.12 · Open Payments source 2025-07-25 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,480.00 · Open Payments source 2025-07-25 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $6,820.00 · Open Payments source 2025-07-25 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $3,100.00 · Open Payments source 2025-07-29 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $537.96 · Open Payments source 2025-07-29 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $296.23 · Open Payments source 2025-07-30 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $386.40 · Open Payments source 2025-07-30 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $258.82 · Open Payments source 2025-07-31 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $339.83 · Open Payments source 2025-08-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4.45 · Open Payments source 2025-08-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $39.97 · Open Payments source 2025-08-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $28.44 · Open Payments source 2025-08-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $23.60 · Open Payments source 2025-08-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $426.36 · Open Payments source 2025-08-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $1,223.34 · Open Payments source 2025-08-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $40.76 · Open Payments source 2025-08-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $6.49 · Open Payments source 2025-08-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $23.77 · Open Payments source 2025-08-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $14,570.00 · Open Payments source 2025-08-02 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $9.81 · Open Payments source 2025-08-02 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $18.66 · Open Payments source 2025-08-03 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $37.12 · Open Payments source 2025-08-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $83.04 · Open Payments source 2025-08-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $140.74 · Open Payments source 2025-08-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $11.21 · Open Payments source 2025-08-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $13.04 · Open Payments source 2025-08-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $10.44 · Open Payments source 2025-08-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $27.31 · Open Payments source 2025-08-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $23.35 · Open Payments source 2025-08-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $7,440.00 · Open Payments source 2025-08-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $3,100.00 · Open Payments source 2025-08-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4,340.00 · Open Payments source 2025-08-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,480.00 · Open Payments source 2025-08-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $182.64 · Open Payments source 2025-08-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $45.98 · Open Payments source 2025-08-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $19.93 · Open Payments source 2025-08-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $19.99 · Open Payments source 2025-08-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $58.38 · Open Payments source 2025-08-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $31.03 · Open Payments source 2025-08-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $17.61 · Open Payments source 2025-08-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $46.33 · Open Payments source 2025-08-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $15.91 · Open Payments source 2025-08-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $15.98 · Open Payments source 2025-08-22 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $31.78 · Open Payments source 2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $115.00 · Open Payments source 2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $138.53 · Open Payments source 2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $20.50 · Open Payments source 2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $24.29 · Open Payments source 2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $24.29 · Open Payments source 2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $275.45 · Open Payments source 2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $423.48 · Open Payments source 2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $46.64 · Open Payments source 2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $52.94 · Open Payments source 2025-10-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $59.43 · Open Payments source 2025-10-11 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $306.75 · Open Payments source 2025-10-11 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $144.19 · Open Payments source 2025-10-11 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $33.76 · Open Payments source 2025-10-11 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $33.76 · Open Payments source 2025-10-11 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $56.87 · Open Payments source 2025-10-11 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $49.33 · Open Payments source 2025-10-11 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $34.57 · Open Payments source 2025-10-11 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $23.10 · Open Payments source 2025-10-13 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $83.55 · Open Payments source 2025-10-23 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $14,570.00 · Open Payments source 2025-10-31 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $34.13 · Open Payments source 2025-10-31 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $48.25 · Open Payments source 2025-10-31 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $49.45 · Open Payments source 2025-10-31 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $30.17 · Open Payments source 2025-10-31 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $48.71 · Open Payments source 2025-11-03 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $431.96 · Open Payments source 2025-11-03 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $176.49 · Open Payments source 2025-11-03 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $878.51 · Open Payments source 2025-11-04 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $676.85 · Open Payments source 2025-11-07 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $7,130.00 · Open Payments source 2025-11-07 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $31.11 · Open Payments source 2025-11-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $23.78 · Open Payments source 2025-11-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $37.88 · Open Payments source 2025-11-28 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $7,750.00 · Open Payments source 2025-12-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $7,440.00 · Open Payments source 2025-12-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $6,820.00 · Open Payments source 2025-12-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,480.00 · Open Payments source 2025-12-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2,480.00 · Open Payments source 2025-12-09 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $620.00 · Open Payments source 2025-12-09 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $298.32 · Open Payments source 2025-12-09 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $720.88 · Open Payments source 2025-12-10 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $323.68 · Open Payments source 2025-12-11 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $326.57 · Open Payments source 2025-12-12 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4,340.00 · Open Payments source 2025-12-12 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $5,115.00 · Open Payments source 2025-12-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $13.11 · Open Payments source 2025-12-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $2.59 · Open Payments source 2025-12-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $48.94 · Open Payments source 2025-12-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $45.92 · Open Payments source 2025-12-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $66.70 · Open Payments source 2025-12-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $44.79 · Open Payments source 2025-12-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $10.76 · Open Payments source 2025-12-15 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $47.73 · Open Payments source 2025-12-23 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $7,440.00 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4,960.00 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4,960.00 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $12.94 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $57.22 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $7.05 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $1,018.14 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $34.75 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $38.33 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $9.76 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $21.40 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $10.00 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $4,340.00 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $9.60 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $38.31 · Open Payments source 2025-12-24 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $53.98 · Open Payments source
Auvelity Normalized: auvelity	Drug	Axsome Therapeutics, Inc.	$183,113.11	164	2025
Source payment records 2025-01-07 · Axsome Therapeutics, Inc. · $2,325.00 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $6,588.00 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $3,488.00 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $7.06 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $142.71 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $20.74 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $38.97 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $61.65 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $298.96 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $72.30 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $896.10 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $1,079.02 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $13.97 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $23.94 · Open Payments source 2025-01-07 · Axsome Therapeutics, Inc. · $67.89 · Open Payments source 2025-01-08 · Axsome Therapeutics, Inc. · $3,488.00 · Open Payments source 2025-01-08 · Axsome Therapeutics, Inc. · $2,325.00 · Open Payments source 2025-01-08 · Axsome Therapeutics, Inc. · $17.98 · Open Payments source 2025-01-08 · Axsome Therapeutics, Inc. · $18.21 · Open Payments source 2025-01-08 · Axsome Therapeutics, Inc. · $82.90 · Open Payments source 2025-01-08 · Axsome Therapeutics, Inc. · $192.57 · Open Payments source 2025-01-08 · Axsome Therapeutics, Inc. · $16.93 · Open Payments source 2025-01-08 · Axsome Therapeutics, Inc. · $21.56 · Open Payments source 2025-01-08 · Axsome Therapeutics, Inc. · $40.97 · Open Payments source 2025-01-08 · Axsome Therapeutics, Inc. · $45.93 · Open Payments source 2025-01-24 · Axsome Therapeutics, Inc. · $5,425.00 · Open Payments source 2025-01-24 · Axsome Therapeutics, Inc. · $3,488.00 · Open Payments source 2025-01-24 · Axsome Therapeutics, Inc. · $124.99 · Open Payments source 2025-01-24 · Axsome Therapeutics, Inc. · $17.67 · Open Payments source 2025-01-24 · Axsome Therapeutics, Inc. · $22.75 · Open Payments source 2025-01-24 · Axsome Therapeutics, Inc. · $10.84 · Open Payments source 2025-01-24 · Axsome Therapeutics, Inc. · $10.84 · Open Payments source 2025-01-24 · Axsome Therapeutics, Inc. · $528.32 · Open Payments source 2025-01-24 · Axsome Therapeutics, Inc. · $41.29 · Open Payments source 2025-01-24 · Axsome Therapeutics, Inc. · $497.97 · Open Payments source 2025-01-24 · Axsome Therapeutics, Inc. · $226.17 · Open Payments source 2025-01-27 · Axsome Therapeutics, Inc. · $2,325.00 · Open Payments source 2025-01-27 · Axsome Therapeutics, Inc. · $3.15 · Open Payments source 2025-01-27 · Axsome Therapeutics, Inc. · $42.22 · Open Payments source 2025-01-27 · Axsome Therapeutics, Inc. · $392.49 · Open Payments source 2025-01-27 · Axsome Therapeutics, Inc. · $58.54 · Open Payments source 2025-02-11 · Axsome Therapeutics, Inc. · $6,588.00 · Open Payments source 2025-02-11 · Axsome Therapeutics, Inc. · $46.11 · Open Payments source 2025-02-11 · Axsome Therapeutics, Inc. · $33.36 · Open Payments source 2025-02-11 · Axsome Therapeutics, Inc. · $586.97 · Open Payments source 2025-02-11 · Axsome Therapeutics, Inc. · $347.63 · Open Payments source 2025-02-12 · Axsome Therapeutics, Inc. · $5,038.00 · Open Payments source 2025-02-12 · Axsome Therapeutics, Inc. · $3,875.00 · Open Payments source 2025-02-12 · Axsome Therapeutics, Inc. · $54.50 · Open Payments source 2025-02-12 · Axsome Therapeutics, Inc. · $30.22 · Open Payments source 2025-02-12 · Axsome Therapeutics, Inc. · $2.02 · Open Payments source 2025-02-12 · Axsome Therapeutics, Inc. · $2.14 · Open Payments source 2025-02-13 · Axsome Therapeutics, Inc. · $5,038.00 · Open Payments source 2025-02-13 · Axsome Therapeutics, Inc. · $29.48 · Open Payments source 2025-02-13 · Axsome Therapeutics, Inc. · $16.90 · Open Payments source 2025-02-13 · Axsome Therapeutics, Inc. · $22.14 · Open Payments source 2025-02-13 · Axsome Therapeutics, Inc. · $367.25 · Open Payments source 2025-02-13 · Axsome Therapeutics, Inc. · $27.43 · Open Payments source 2025-02-13 · Axsome Therapeutics, Inc. · $14.98 · Open Payments source 2025-02-13 · Axsome Therapeutics, Inc. · $300.32 · Open Payments source 2025-02-13 · Axsome Therapeutics, Inc. · $292.67 · Open Payments source 2025-03-01 · Axsome Therapeutics, Inc. · $20.05 · Open Payments source 2025-03-01 · Axsome Therapeutics, Inc. · $31.47 · Open Payments source 2025-03-01 · Axsome Therapeutics, Inc. · $34.24 · Open Payments source 2025-03-01 · Axsome Therapeutics, Inc. · $49.45 · Open Payments source 2025-03-01 · Axsome Therapeutics, Inc. · $74.19 · Open Payments source 2025-03-01 · Axsome Therapeutics, Inc. · $93.70 · Open Payments source 2025-03-01 · Axsome Therapeutics, Inc. · $110.26 · Open Payments source 2025-03-01 · Axsome Therapeutics, Inc. · $24.73 · Open Payments source 2025-03-01 · Axsome Therapeutics, Inc. · $24.73 · Open Payments source 2025-03-01 · Axsome Therapeutics, Inc. · $303.97 · Open Payments source 2025-03-15 · Axsome Therapeutics, Inc. · $50.60 · Open Payments source 2025-03-15 · Axsome Therapeutics, Inc. · $125.13 · Open Payments source 2025-03-15 · Axsome Therapeutics, Inc. · $48.79 · Open Payments source 2025-03-15 · Axsome Therapeutics, Inc. · $32.93 · Open Payments source 2025-03-15 · Axsome Therapeutics, Inc. · $78.04 · Open Payments source 2025-03-15 · Axsome Therapeutics, Inc. · $60.36 · Open Payments source 2025-03-15 · Axsome Therapeutics, Inc. · $45.30 · Open Payments source 2025-03-15 · Axsome Therapeutics, Inc. · $29.45 · Open Payments source 2025-03-15 · Axsome Therapeutics, Inc. · $26.77 · Open Payments source 2025-03-15 · Axsome Therapeutics, Inc. · $469.66 · Open Payments source 2025-03-15 · Axsome Therapeutics, Inc. · $795.96 · Open Payments source 2025-03-25 · Axsome Therapeutics, Inc. · $1,650.00 · Open Payments source 2025-03-25 · Axsome Therapeutics, Inc. · $7,013.00 · Open Payments source 2025-03-25 · Axsome Therapeutics, Inc. · $138.36 · Open Payments source 2025-03-25 · Axsome Therapeutics, Inc. · $18.62 · Open Payments source 2025-03-25 · Axsome Therapeutics, Inc. · $35.32 · Open Payments source 2025-03-25 · Axsome Therapeutics, Inc. · $3.30 · Open Payments source 2025-03-25 · Axsome Therapeutics, Inc. · $30.19 · Open Payments source 2025-03-25 · Axsome Therapeutics, Inc. · $34.47 · Open Payments source 2025-03-25 · Axsome Therapeutics, Inc. · $350.85 · Open Payments source 2025-03-25 · Axsome Therapeutics, Inc. · $612.97 · Open Payments source 2025-03-26 · Axsome Therapeutics, Inc. · $3,713.00 · Open Payments source 2025-03-26 · Axsome Therapeutics, Inc. · $1,650.00 · Open Payments source 2025-03-26 · Axsome Therapeutics, Inc. · $33.54 · Open Payments source 2025-03-26 · Axsome Therapeutics, Inc. · $272.11 · Open Payments source 2025-03-26 · Axsome Therapeutics, Inc. · $30.00 · Open Payments source 2025-03-27 · Axsome Therapeutics, Inc. · $4,125.00 · Open Payments source 2025-03-27 · Axsome Therapeutics, Inc. · $3,713.00 · Open Payments source 2025-03-27 · Axsome Therapeutics, Inc. · $19.24 · Open Payments source 2025-03-27 · Axsome Therapeutics, Inc. · $6.07 · Open Payments source 2025-03-27 · Axsome Therapeutics, Inc. · $11.08 · Open Payments source 2025-03-27 · Axsome Therapeutics, Inc. · $27.65 · Open Payments source 2025-03-27 · Axsome Therapeutics, Inc. · $34.36 · Open Payments source 2025-03-27 · Axsome Therapeutics, Inc. · $261.46 · Open Payments source 2025-03-27 · Axsome Therapeutics, Inc. · $47.92 · Open Payments source 2025-03-27 · Axsome Therapeutics, Inc. · $377.96 · Open Payments source 2025-03-27 · Axsome Therapeutics, Inc. · $41.73 · Open Payments source 2025-03-31 · Axsome Therapeutics, Inc. · $16.27 · Open Payments source 2025-03-31 · Axsome Therapeutics, Inc. · $24.00 · Open Payments source 2025-03-31 · Axsome Therapeutics, Inc. · $16.80 · Open Payments source 2025-04-04 · Axsome Therapeutics, Inc. · $9,487.50 · Open Payments source 2025-04-04 · Axsome Therapeutics, Inc. · $14,025.00 · Open Payments source 2025-04-08 · Axsome Therapeutics, Inc. · $12,375.00 · Open Payments source 2025-04-08 · Axsome Therapeutics, Inc. · $18.39 · Open Payments source 2025-04-08 · Axsome Therapeutics, Inc. · $41.96 · Open Payments source 2025-05-30 · Axsome Therapeutics, Inc. · $150.00 · Open Payments source 2025-06-17 · Axsome Therapeutics, Inc. · $2,062.50 · Open Payments source 2025-07-09 · Axsome Therapeutics, Inc. · $145.41 · Open Payments source 2025-07-25 · Axsome Therapeutics, Inc. · $407.38 · Open Payments source 2025-07-25 · Axsome Therapeutics, Inc. · $496.97 · Open Payments source 2025-07-25 · Axsome Therapeutics, Inc. · $407.38 · Open Payments source 2025-07-25 · Axsome Therapeutics, Inc. · $496.97 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $11,550.00 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $55.91 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $6.94 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $48.31 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $75.09 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $151.77 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $53.05 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $11,550.00 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $55.91 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $6.94 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $48.31 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $75.09 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $151.77 · Open Payments source 2025-08-15 · Axsome Therapeutics, Inc. · $53.05 · Open Payments source 2025-10-10 · Axsome Therapeutics, Inc. · $7,838.00 · Open Payments source 2025-11-07 · Axsome Therapeutics, Inc. · $74.58 · Open Payments source 2025-11-22 · Axsome Therapeutics, Inc. · $5,775.00 · Open Payments source 2025-11-22 · Axsome Therapeutics, Inc. · $182.85 · Open Payments source 2025-11-24 · Axsome Therapeutics, Inc. · $3,713.00 · Open Payments source 2025-11-24 · Axsome Therapeutics, Inc. · $5,775.00 · Open Payments source 2025-11-24 · Axsome Therapeutics, Inc. · $21.58 · Open Payments source 2025-11-24 · Axsome Therapeutics, Inc. · $53.82 · Open Payments source 2025-11-24 · Axsome Therapeutics, Inc. · $12.95 · Open Payments source 2025-11-24 · Axsome Therapeutics, Inc. · $446.32 · Open Payments source 2025-11-24 · Axsome Therapeutics, Inc. · $23.87 · Open Payments source 2025-11-24 · Axsome Therapeutics, Inc. · $12.18 · Open Payments source 2025-11-24 · Axsome Therapeutics, Inc. · $58.59 · Open Payments source 2025-11-24 · Axsome Therapeutics, Inc. · $35.93 · Open Payments source 2025-11-24 · Axsome Therapeutics, Inc. · $426.96 · Open Payments source 2025-11-24 · Axsome Therapeutics, Inc. · $761.50 · Open Payments source 2025-11-25 · Axsome Therapeutics, Inc. · $4,125.00 · Open Payments source 2025-11-25 · Axsome Therapeutics, Inc. · $5,363.00 · Open Payments source 2025-11-25 · Axsome Therapeutics, Inc. · $113.53 · Open Payments source 2025-11-25 · Axsome Therapeutics, Inc. · $19.83 · Open Payments source 2025-11-25 · Axsome Therapeutics, Inc. · $45.15 · Open Payments source 2025-11-25 · Axsome Therapeutics, Inc. · $4.66 · Open Payments source 2025-11-25 · Axsome Therapeutics, Inc. · $33.54 · Open Payments source 2025-11-25 · Axsome Therapeutics, Inc. · $15.96 · Open Payments source 2025-11-25 · Axsome Therapeutics, Inc. · $26.95 · Open Payments source 2025-11-25 · Axsome Therapeutics, Inc. · $11.99 · Open Payments source 2025-11-25 · Axsome Therapeutics, Inc. · $4.00 · Open Payments source
INGREZZA Normalized: ingrezza	Drug	Neurocrine BioSciences, Inc.	$159,786.98	167	2025
Source payment records 2025-03-07 · Neurocrine BioSciences, Inc. · $354.66 · Open Payments source 2025-03-07 · Neurocrine BioSciences, Inc. · $175.00 · Open Payments source 2025-03-07 · Neurocrine BioSciences, Inc. · $31.29 · Open Payments source 2025-03-08 · Neurocrine BioSciences, Inc. · $434.79 · Open Payments source 2025-03-08 · Neurocrine BioSciences, Inc. · $242.97 · Open Payments source 2025-03-08 · Neurocrine BioSciences, Inc. · $61.72 · Open Payments source 2025-03-08 · Neurocrine BioSciences, Inc. · $60.05 · Open Payments source 2025-03-08 · Neurocrine BioSciences, Inc. · $54.80 · Open Payments source 2025-03-08 · Neurocrine BioSciences, Inc. · $37.65 · Open Payments source 2025-03-08 · Neurocrine BioSciences, Inc. · $32.29 · Open Payments source 2025-03-08 · Neurocrine BioSciences, Inc. · $9.85 · Open Payments source 2025-03-08 · Neurocrine BioSciences, Inc. · $6.60 · Open Payments source 2025-03-09 · Neurocrine BioSciences, Inc. · $45.90 · Open Payments source 2025-04-01 · Neurocrine BioSciences, Inc. · $5,463.00 · Open Payments source 2025-04-01 · Neurocrine BioSciences, Inc. · $799.84 · Open Payments source 2025-04-01 · Neurocrine BioSciences, Inc. · $726.96 · Open Payments source 2025-04-01 · Neurocrine BioSciences, Inc. · $32.91 · Open Payments source 2025-04-01 · Neurocrine BioSciences, Inc. · $18.63 · Open Payments source 2025-04-01 · Neurocrine BioSciences, Inc. · $15.27 · Open Payments source 2025-04-01 · Neurocrine BioSciences, Inc. · $407.47 · Open Payments source 2025-04-01 · Neurocrine BioSciences, Inc. · $113.49 · Open Payments source 2025-04-02 · Neurocrine BioSciences, Inc. · $3,738.00 · Open Payments source 2025-04-02 · Neurocrine BioSciences, Inc. · $26.49 · Open Payments source 2025-04-02 · Neurocrine BioSciences, Inc. · $25.73 · Open Payments source 2025-04-02 · Neurocrine BioSciences, Inc. · $11.34 · Open Payments source 2025-04-02 · Neurocrine BioSciences, Inc. · $3,738.00 · Open Payments source 2025-04-03 · Neurocrine BioSciences, Inc. · $11,212.50 · Open Payments source 2025-04-03 · Neurocrine BioSciences, Inc. · $447.13 · Open Payments source 2025-04-03 · Neurocrine BioSciences, Inc. · $20.20 · Open Payments source 2025-04-03 · Neurocrine BioSciences, Inc. · $12.34 · Open Payments source 2025-04-03 · Neurocrine BioSciences, Inc. · $4.30 · Open Payments source 2025-04-03 · Neurocrine BioSciences, Inc. · $3,738.00 · Open Payments source 2025-04-03 · Neurocrine BioSciences, Inc. · $3,738.00 · Open Payments source 2025-04-11 · Neurocrine BioSciences, Inc. · $37.75 · Open Payments source 2025-04-11 · Neurocrine BioSciences, Inc. · $12.48 · Open Payments source 2025-04-11 · Neurocrine BioSciences, Inc. · $9.23 · Open Payments source 2025-05-19 · Neurocrine BioSciences, Inc. · $39.32 · Open Payments source 2025-06-24 · Neurocrine BioSciences, Inc. · $5,463.00 · Open Payments source 2025-06-24 · Neurocrine BioSciences, Inc. · $3,738.00 · Open Payments source 2025-06-24 · Neurocrine BioSciences, Inc. · $515.96 · Open Payments source 2025-06-24 · Neurocrine BioSciences, Inc. · $245.37 · Open Payments source 2025-06-24 · Neurocrine BioSciences, Inc. · $45.97 · Open Payments source 2025-06-24 · Neurocrine BioSciences, Inc. · $36.00 · Open Payments source 2025-06-24 · Neurocrine BioSciences, Inc. · $31.92 · Open Payments source 2025-06-24 · Neurocrine BioSciences, Inc. · $299.96 · Open Payments source 2025-06-24 · Neurocrine BioSciences, Inc. · $12.54 · Open Payments source 2025-06-25 · Neurocrine BioSciences, Inc. · $4,600.00 · Open Payments source 2025-06-25 · Neurocrine BioSciences, Inc. · $3,738.00 · Open Payments source 2025-06-25 · Neurocrine BioSciences, Inc. · $154.10 · Open Payments source 2025-06-25 · Neurocrine BioSciences, Inc. · $32.65 · Open Payments source 2025-06-25 · Neurocrine BioSciences, Inc. · $16.49 · Open Payments source 2025-06-25 · Neurocrine BioSciences, Inc. · $5.11 · Open Payments source 2025-06-26 · Neurocrine BioSciences, Inc. · $4,600.00 · Open Payments source 2025-06-26 · Neurocrine BioSciences, Inc. · $191.52 · Open Payments source 2025-06-26 · Neurocrine BioSciences, Inc. · $52.99 · Open Payments source 2025-06-26 · Neurocrine BioSciences, Inc. · $25.50 · Open Payments source 2025-06-26 · Neurocrine BioSciences, Inc. · $23.98 · Open Payments source 2025-06-26 · Neurocrine BioSciences, Inc. · $22.94 · Open Payments source 2025-06-26 · Neurocrine BioSciences, Inc. · $14.70 · Open Payments source 2025-06-26 · Neurocrine BioSciences, Inc. · $2.66 · Open Payments source 2025-07-07 · Neurocrine BioSciences, Inc. · $574.96 · Open Payments source 2025-07-19 · Neurocrine BioSciences, Inc. · $332.13 · Open Payments source 2025-07-19 · Neurocrine BioSciences, Inc. · $147.28 · Open Payments source 2025-07-19 · Neurocrine BioSciences, Inc. · $145.62 · Open Payments source 2025-07-19 · Neurocrine BioSciences, Inc. · $139.20 · Open Payments source 2025-08-05 · Neurocrine BioSciences, Inc. · $5,463.00 · Open Payments source 2025-08-05 · Neurocrine BioSciences, Inc. · $670.45 · Open Payments source 2025-08-05 · Neurocrine BioSciences, Inc. · $269.97 · Open Payments source 2025-08-05 · Neurocrine BioSciences, Inc. · $44.89 · Open Payments source 2025-08-05 · Neurocrine BioSciences, Inc. · $43.62 · Open Payments source 2025-08-05 · Neurocrine BioSciences, Inc. · $40.20 · Open Payments source 2025-08-05 · Neurocrine BioSciences, Inc. · $11.91 · Open Payments source 2025-08-05 · Neurocrine BioSciences, Inc. · $7.92 · Open Payments source 2025-08-06 · Neurocrine BioSciences, Inc. · $3,738.00 · Open Payments source 2025-08-06 · Neurocrine BioSciences, Inc. · $3,738.00 · Open Payments source 2025-08-06 · Neurocrine BioSciences, Inc. · $370.87 · Open Payments source 2025-08-06 · Neurocrine BioSciences, Inc. · $114.06 · Open Payments source 2025-08-06 · Neurocrine BioSciences, Inc. · $56.32 · Open Payments source 2025-08-06 · Neurocrine BioSciences, Inc. · $49.67 · Open Payments source 2025-08-06 · Neurocrine BioSciences, Inc. · $42.97 · Open Payments source 2025-08-06 · Neurocrine BioSciences, Inc. · $40.15 · Open Payments source 2025-08-06 · Neurocrine BioSciences, Inc. · $33.79 · Open Payments source 2025-08-06 · Neurocrine BioSciences, Inc. · $32.61 · Open Payments source 2025-08-06 · Neurocrine BioSciences, Inc. · $29.97 · Open Payments source 2025-08-13 · Neurocrine BioSciences, Inc. · $5,463.00 · Open Payments source 2025-08-13 · Neurocrine BioSciences, Inc. · $3,738.00 · Open Payments source 2025-08-13 · Neurocrine BioSciences, Inc. · $216.81 · Open Payments source 2025-08-13 · Neurocrine BioSciences, Inc. · $57.60 · Open Payments source 2025-08-13 · Neurocrine BioSciences, Inc. · $45.93 · Open Payments source 2025-08-13 · Neurocrine BioSciences, Inc. · $19.54 · Open Payments source 2025-08-13 · Neurocrine BioSciences, Inc. · $14.54 · Open Payments source 2025-08-14 · Neurocrine BioSciences, Inc. · $4,600.00 · Open Payments source 2025-08-14 · Neurocrine BioSciences, Inc. · $3,738.00 · Open Payments source 2025-08-14 · Neurocrine BioSciences, Inc. · $521.79 · Open Payments source 2025-08-14 · Neurocrine BioSciences, Inc. · $258.68 · Open Payments source 2025-08-14 · Neurocrine BioSciences, Inc. · $220.15 · Open Payments source 2025-08-14 · Neurocrine BioSciences, Inc. · $25.48 · Open Payments source 2025-08-14 · Neurocrine BioSciences, Inc. · $24.68 · Open Payments source 2025-08-14 · Neurocrine BioSciences, Inc. · $19.16 · Open Payments source 2025-08-14 · Neurocrine BioSciences, Inc. · $13.35 · Open Payments source 2025-08-14 · Neurocrine BioSciences, Inc. · $12.72 · Open Payments source 2025-08-15 · Neurocrine BioSciences, Inc. · $7,762.50 · Open Payments source 2025-08-19 · Neurocrine BioSciences, Inc. · $5,463.00 · Open Payments source 2025-08-19 · Neurocrine BioSciences, Inc. · $732.57 · Open Payments source 2025-08-19 · Neurocrine BioSciences, Inc. · $543.97 · Open Payments source 2025-08-19 · Neurocrine BioSciences, Inc. · $35.95 · Open Payments source 2025-08-19 · Neurocrine BioSciences, Inc. · $31.30 · Open Payments source 2025-08-19 · Neurocrine BioSciences, Inc. · $31.21 · Open Payments source 2025-08-19 · Neurocrine BioSciences, Inc. · $16.78 · Open Payments source 2025-08-20 · Neurocrine BioSciences, Inc. · $3,738.00 · Open Payments source 2025-08-20 · Neurocrine BioSciences, Inc. · $3,738.00 · Open Payments source 2025-08-20 · Neurocrine BioSciences, Inc. · $233.08 · Open Payments source 2025-08-20 · Neurocrine BioSciences, Inc. · $53.29 · Open Payments source 2025-08-20 · Neurocrine BioSciences, Inc. · $37.66 · Open Payments source 2025-08-20 · Neurocrine BioSciences, Inc. · $34.50 · Open Payments source 2025-08-20 · Neurocrine BioSciences, Inc. · $18.00 · Open Payments source 2025-08-20 · Neurocrine BioSciences, Inc. · $17.07 · Open Payments source 2025-08-20 · Neurocrine BioSciences, Inc. · $3.00 · Open Payments source 2025-08-20 · Neurocrine BioSciences, Inc. · $5.00 · Open Payments source 2025-08-20 · Neurocrine BioSciences, Inc. · $5.00 · Open Payments source 2025-08-22 · Neurocrine BioSciences, Inc. · $110.29 · Open Payments source 2025-08-22 · Neurocrine BioSciences, Inc. · $46.26 · Open Payments source 2025-08-25 · Neurocrine BioSciences, Inc. · $2,875.00 · Open Payments source 2025-08-29 · Neurocrine BioSciences, Inc. · $52.92 · Open Payments source 2025-08-29 · Neurocrine BioSciences, Inc. · $48.42 · Open Payments source 2025-08-29 · Neurocrine BioSciences, Inc. · $3,738.00 · Open Payments source 2025-09-05 · Neurocrine BioSciences, Inc. · $1,438.00 · Open Payments source 2025-09-29 · Neurocrine BioSciences, Inc. · $920.42 · Open Payments source 2025-09-29 · Neurocrine BioSciences, Inc. · $458.97 · Open Payments source 2025-09-29 · Neurocrine BioSciences, Inc. · $343.48 · Open Payments source 2025-09-29 · Neurocrine BioSciences, Inc. · $165.65 · Open Payments source 2025-09-29 · Neurocrine BioSciences, Inc. · $86.78 · Open Payments source 2025-09-29 · Neurocrine BioSciences, Inc. · $78.15 · Open Payments source 2025-09-29 · Neurocrine BioSciences, Inc. · $70.55 · Open Payments source 2025-09-29 · Neurocrine BioSciences, Inc. · $32.88 · Open Payments source 2025-09-29 · Neurocrine BioSciences, Inc. · $27.66 · Open Payments source 2025-09-29 · Neurocrine BioSciences, Inc. · $26.85 · Open Payments source 2025-09-29 · Neurocrine BioSciences, Inc. · $6.99 · Open Payments source 2025-10-17 · Neurocrine BioSciences, Inc. · $12,362.50 · Open Payments source 2025-10-31 · Neurocrine BioSciences, Inc. · $97.45 · Open Payments source 2025-10-31 · Neurocrine BioSciences, Inc. · $60.80 · Open Payments source 2025-10-31 · Neurocrine BioSciences, Inc. · $36.09 · Open Payments source 2025-10-31 · Neurocrine BioSciences, Inc. · $35.94 · Open Payments source 2025-10-31 · Neurocrine BioSciences, Inc. · $31.31 · Open Payments source 2025-10-31 · Neurocrine BioSciences, Inc. · $30.98 · Open Payments source 2025-10-31 · Neurocrine BioSciences, Inc. · $21.97 · Open Payments source 2025-10-31 · Neurocrine BioSciences, Inc. · $14.93 · Open Payments source 2025-10-31 · Neurocrine BioSciences, Inc. · $13.89 · Open Payments source 2025-11-05 · Neurocrine BioSciences, Inc. · $278.79 · Open Payments source 2025-11-05 · Neurocrine BioSciences, Inc. · $265.48 · Open Payments source 2025-11-05 · Neurocrine BioSciences, Inc. · $265.07 · Open Payments source 2025-11-05 · Neurocrine BioSciences, Inc. · $229.87 · Open Payments source 2025-11-05 · Neurocrine BioSciences, Inc. · $149.48 · Open Payments source 2025-11-05 · Neurocrine BioSciences, Inc. · $68.48 · Open Payments source 2025-11-05 · Neurocrine BioSciences, Inc. · $48.39 · Open Payments source 2025-11-05 · Neurocrine BioSciences, Inc. · $45.65 · Open Payments source 2025-11-05 · Neurocrine BioSciences, Inc. · $24.19 · Open Payments source 2025-11-05 · Neurocrine BioSciences, Inc. · $24.19 · Open Payments source 2025-11-06 · Neurocrine BioSciences, Inc. · $1,438.00 · Open Payments source 2025-11-08 · Neurocrine BioSciences, Inc. · $33.29 · Open Payments source 2025-11-09 · Neurocrine BioSciences, Inc. · $34.41 · Open Payments source 2025-11-09 · Neurocrine BioSciences, Inc. · $8.76 · Open Payments source 2025-11-20 · Neurocrine BioSciences, Inc. · $6,325.00 · Open Payments source 2025-11-20 · Neurocrine BioSciences, Inc. · $1,438.00 · Open Payments source 2025-11-28 · Neurocrine BioSciences, Inc. · $8,337.50 · Open Payments source 2025-11-28 · Neurocrine BioSciences, Inc. · $64.40 · Open Payments source 2025-11-28 · Neurocrine BioSciences, Inc. · $42.72 · Open Payments source
VRAYLAR Normalized: vraylar	Drug	ABBVIE INC.	$128,722.97	114	2025
Source payment records 2025-01-13 · ABBVIE INC. · $989.53 · Open Payments source 2025-01-13 · ABBVIE INC. · $83.96 · Open Payments source 2025-01-13 · ABBVIE INC. · $18.38 · Open Payments source 2025-01-13 · ABBVIE INC. · $45.18 · Open Payments source 2025-01-14 · ABBVIE INC. · $7.03 · Open Payments source 2025-01-14 · ABBVIE INC. · $1,110.71 · Open Payments source 2025-01-14 · ABBVIE INC. · $125.00 · Open Payments source 2025-01-14 · ABBVIE INC. · $11.87 · Open Payments source 2025-01-14 · ABBVIE INC. · $23.97 · Open Payments source 2025-01-14 · ABBVIE INC. · $605.95 · Open Payments source 2025-01-15 · ABBVIE INC. · $18.21 · Open Payments source 2025-01-15 · ABBVIE INC. · $6.92 · Open Payments source 2025-01-15 · ABBVIE INC. · $31.42 · Open Payments source 2025-01-16 · ABBVIE INC. · $23.42 · Open Payments source 2025-01-16 · ABBVIE INC. · $35.52 · Open Payments source 2025-01-16 · ABBVIE INC. · $16.38 · Open Payments source 2025-01-17 · ABBVIE INC. · $24.34 · Open Payments source 2025-01-28 · ABBVIE INC. · $4,725.00 · Open Payments source 2025-01-28 · ABBVIE INC. · $4,725.00 · Open Payments source 2025-02-04 · ABBVIE INC. · $4,725.00 · Open Payments source 2025-02-04 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-02-04 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-02-04 · ABBVIE INC. · $4,725.00 · Open Payments source 2025-02-10 · ABBVIE INC. · $365.63 · Open Payments source 2025-02-13 · ABBVIE INC. · $515.88 · Open Payments source 2025-02-25 · ABBVIE INC. · $10.71 · Open Payments source 2025-02-25 · ABBVIE INC. · $12.54 · Open Payments source 2025-02-25 · ABBVIE INC. · $33.97 · Open Payments source 2025-02-25 · ABBVIE INC. · $42.98 · Open Payments source 2025-02-25 · ABBVIE INC. · $377.96 · Open Payments source 2025-02-25 · ABBVIE INC. · $394.37 · Open Payments source 2025-02-25 · ABBVIE INC. · $122.75 · Open Payments source 2025-02-26 · ABBVIE INC. · $19.38 · Open Payments source 2025-02-26 · ABBVIE INC. · $27.73 · Open Payments source 2025-02-26 · ABBVIE INC. · $36.83 · Open Payments source 2025-02-26 · ABBVIE INC. · $594.00 · Open Payments source 2025-02-27 · ABBVIE INC. · $10.93 · Open Payments source 2025-02-27 · ABBVIE INC. · $33.60 · Open Payments source 2025-02-27 · ABBVIE INC. · $38.59 · Open Payments source 2025-02-27 · ABBVIE INC. · $474.07 · Open Payments source 2025-02-28 · ABBVIE INC. · $3.37 · Open Payments source 2025-02-28 · ABBVIE INC. · $21.63 · Open Payments source 2025-03-04 · ABBVIE INC. · $35.95 · Open Payments source 2025-03-04 · ABBVIE INC. · $100.24 · Open Payments source 2025-03-04 · ABBVIE INC. · $8,100.00 · Open Payments source 2025-03-11 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-03-18 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-03-18 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-03-18 · ABBVIE INC. · $4,725.00 · Open Payments source 2025-03-25 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-05-27 · ABBVIE INC. · $1,350.00 · Open Payments source 2025-06-05 · ABBVIE INC. · $1,012.50 · Open Payments source 2025-07-22 · ABBVIE INC. · $173.27 · Open Payments source 2025-07-22 · ABBVIE INC. · $40.99 · Open Payments source 2025-07-22 · ABBVIE INC. · $762.49 · Open Payments source 2025-07-22 · ABBVIE INC. · $33.41 · Open Payments source 2025-07-22 · ABBVIE INC. · $796.00 · Open Payments source 2025-07-23 · ABBVIE INC. · $26.48 · Open Payments source 2025-07-23 · ABBVIE INC. · $309.56 · Open Payments source 2025-07-23 · ABBVIE INC. · $421.80 · Open Payments source 2025-07-23 · ABBVIE INC. · $11.06 · Open Payments source 2025-07-23 · ABBVIE INC. · $28.94 · Open Payments source 2025-07-23 · ABBVIE INC. · $328.78 · Open Payments source 2025-07-23 · ABBVIE INC. · $738.15 · Open Payments source 2025-07-24 · ABBVIE INC. · $421.80 · Open Payments source 2025-07-24 · ABBVIE INC. · $23.75 · Open Payments source 2025-07-24 · ABBVIE INC. · $25.61 · Open Payments source 2025-07-29 · ABBVIE INC. · $1,350.00 · Open Payments source 2025-08-08 · ABBVIE INC. · $4,725.00 · Open Payments source 2025-08-08 · ABBVIE INC. · $4,725.00 · Open Payments source 2025-08-08 · ABBVIE INC. · $4,725.00 · Open Payments source 2025-08-08 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-08-14 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-08-19 · ABBVIE INC. · $1,181.25 · Open Payments source 2025-08-19 · ABBVIE INC. · $506.25 · Open Payments source 2025-09-30 · ABBVIE INC. · $168.98 · Open Payments source 2025-10-01 · ABBVIE INC. · $25.41 · Open Payments source 2025-10-01 · ABBVIE INC. · $734.96 · Open Payments source 2025-10-01 · ABBVIE INC. · $593.52 · Open Payments source 2025-10-01 · ABBVIE INC. · $16.07 · Open Payments source 2025-10-02 · ABBVIE INC. · $15.48 · Open Payments source 2025-10-02 · ABBVIE INC. · $25.00 · Open Payments source 2025-10-02 · ABBVIE INC. · $247.79 · Open Payments source 2025-10-03 · ABBVIE INC. · $19.59 · Open Payments source 2025-10-16 · ABBVIE INC. · $4,725.00 · Open Payments source 2025-10-16 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-10-16 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-11-18 · ABBVIE INC. · $124.99 · Open Payments source 2025-11-18 · ABBVIE INC. · $507.80 · Open Payments source 2025-11-18 · ABBVIE INC. · $63.15 · Open Payments source 2025-11-18 · ABBVIE INC. · $14.53 · Open Payments source 2025-11-18 · ABBVIE INC. · $44.78 · Open Payments source 2025-11-18 · ABBVIE INC. · $192.26 · Open Payments source 2025-11-18 · ABBVIE INC. · $905.05 · Open Payments source 2025-11-18 · ABBVIE INC. · $4.56 · Open Payments source 2025-11-18 · ABBVIE INC. · $667.70 · Open Payments source 2025-11-19 · ABBVIE INC. · $429.68 · Open Payments source 2025-11-19 · ABBVIE INC. · $61.35 · Open Payments source 2025-11-19 · ABBVIE INC. · $9.68 · Open Payments source 2025-11-19 · ABBVIE INC. · $33.61 · Open Payments source 2025-11-19 · ABBVIE INC. · $742.17 · Open Payments source 2025-11-20 · ABBVIE INC. · $4.87 · Open Payments source 2025-11-20 · ABBVIE INC. · $17.61 · Open Payments source 2025-11-20 · ABBVIE INC. · $351.56 · Open Payments source 2025-11-20 · ABBVIE INC. · $21.44 · Open Payments source 2025-11-20 · ABBVIE INC. · $67.82 · Open Payments source 2025-11-20 · ABBVIE INC. · $252.95 · Open Payments source 2025-11-20 · ABBVIE INC. · $390.62 · Open Payments source 2025-12-04 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-12-04 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-12-04 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-12-04 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-12-11 · ABBVIE INC. · $3,375.00 · Open Payments source 2025-12-11 · ABBVIE INC. · $4,725.00 · Open Payments source
LYBALVI Normalized: lybalvi	Drug	Alkermes, Inc.	$116,682.67	108	2025
Source payment records 2025-01-28 · Alkermes, Inc. · $303.97 · Open Payments source 2025-01-28 · Alkermes, Inc. · $356.80 · Open Payments source 2025-02-18 · Alkermes, Inc. · $617.97 · Open Payments source 2025-02-18 · Alkermes, Inc. · $897.18 · Open Payments source 2025-03-18 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-03-18 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-03-18 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-03-18 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-03-18 · Alkermes, Inc. · $3,635.00 · Open Payments source 2025-03-18 · Alkermes, Inc. · $3,635.00 · Open Payments source 2025-03-18 · Alkermes, Inc. · $501.97 · Open Payments source 2025-03-18 · Alkermes, Inc. · $261.46 · Open Payments source 2025-03-18 · Alkermes, Inc. · $256.95 · Open Payments source 2025-03-19 · Alkermes, Inc. · $24.77 · Open Payments source 2025-03-20 · Alkermes, Inc. · $74.76 · Open Payments source 2025-03-20 · Alkermes, Inc. · $43.64 · Open Payments source 2025-03-20 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-03-20 · Alkermes, Inc. · $67.20 · Open Payments source 2025-03-20 · Alkermes, Inc. · $98.70 · Open Payments source 2025-03-20 · Alkermes, Inc. · $81.05 · Open Payments source 2025-03-20 · Alkermes, Inc. · $468.72 · Open Payments source 2025-03-20 · Alkermes, Inc. · $23.11 · Open Payments source 2025-03-20 · Alkermes, Inc. · $41.18 · Open Payments source 2025-03-20 · Alkermes, Inc. · $29.05 · Open Payments source 2025-03-20 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-03-20 · Alkermes, Inc. · $29.85 · Open Payments source 2025-03-20 · Alkermes, Inc. · $10.00 · Open Payments source 2025-03-20 · Alkermes, Inc. · $230.39 · Open Payments source 2025-03-24 · Alkermes, Inc. · $6,565.00 · Open Payments source 2025-04-04 · Alkermes, Inc. · $57.77 · Open Payments source 2025-04-04 · Alkermes, Inc. · $16.00 · Open Payments source 2025-04-04 · Alkermes, Inc. · $17.16 · Open Payments source 2025-04-04 · Alkermes, Inc. · $49.27 · Open Payments source 2025-04-04 · Alkermes, Inc. · $44.65 · Open Payments source 2025-04-04 · Alkermes, Inc. · $34.85 · Open Payments source 2025-04-04 · Alkermes, Inc. · $72.58 · Open Payments source 2025-04-04 · Alkermes, Inc. · $72.58 · Open Payments source 2025-04-04 · Alkermes, Inc. · $15.87 · Open Payments source 2025-04-04 · Alkermes, Inc. · $23.27 · Open Payments source 2025-04-04 · Alkermes, Inc. · $125.00 · Open Payments source 2025-04-04 · Alkermes, Inc. · $24.95 · Open Payments source 2025-04-05 · Alkermes, Inc. · $764.96 · Open Payments source 2025-04-05 · Alkermes, Inc. · $238.26 · Open Payments source 2025-04-05 · Alkermes, Inc. · $2.88 · Open Payments source 2025-04-05 · Alkermes, Inc. · $23.27 · Open Payments source 2025-04-05 · Alkermes, Inc. · $60.00 · Open Payments source 2025-04-05 · Alkermes, Inc. · $48.66 · Open Payments source 2025-04-05 · Alkermes, Inc. · $75.00 · Open Payments source 2025-04-05 · Alkermes, Inc. · $17.85 · Open Payments source 2025-04-05 · Alkermes, Inc. · $23.00 · Open Payments source 2025-04-11 · Alkermes, Inc. · $2,950.00 · Open Payments source 2025-04-11 · Alkermes, Inc. · $43.29 · Open Payments source 2025-04-11 · Alkermes, Inc. · $30.81 · Open Payments source 2025-04-11 · Alkermes, Inc. · $2,950.00 · Open Payments source 2025-04-11 · Alkermes, Inc. · $2,950.00 · Open Payments source 2025-04-11 · Alkermes, Inc. · $2,950.00 · Open Payments source 2025-04-11 · Alkermes, Inc. · $49.68 · Open Payments source 2025-04-11 · Alkermes, Inc. · $560.40 · Open Payments source 2025-04-11 · Alkermes, Inc. · $3,635.00 · Open Payments source 2025-04-11 · Alkermes, Inc. · $3,635.00 · Open Payments source 2025-04-25 · Alkermes, Inc. · $9,540.00 · Open Payments source 2025-05-13 · Alkermes, Inc. · $57.40 · Open Payments source 2025-05-13 · Alkermes, Inc. · $13.15 · Open Payments source 2025-05-13 · Alkermes, Inc. · $21.41 · Open Payments source 2025-06-03 · Alkermes, Inc. · $183.48 · Open Payments source 2025-06-03 · Alkermes, Inc. · $439.10 · Open Payments source 2025-06-16 · Alkermes, Inc. · $903.77 · Open Payments source 2025-06-16 · Alkermes, Inc. · $1,188.97 · Open Payments source 2025-06-18 · Alkermes, Inc. · $3,635.00 · Open Payments source 2025-06-18 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-06-18 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-06-18 · Alkermes, Inc. · $3,635.00 · Open Payments source 2025-07-03 · Alkermes, Inc. · $61.25 · Open Payments source 2025-07-03 · Alkermes, Inc. · $41.94 · Open Payments source 2025-07-03 · Alkermes, Inc. · $50.58 · Open Payments source 2025-07-03 · Alkermes, Inc. · $240.78 · Open Payments source 2025-07-03 · Alkermes, Inc. · $38.76 · Open Payments source 2025-07-03 · Alkermes, Inc. · $22.39 · Open Payments source 2025-07-03 · Alkermes, Inc. · $62.38 · Open Payments source 2025-07-03 · Alkermes, Inc. · $35.09 · Open Payments source 2025-07-03 · Alkermes, Inc. · $48.96 · Open Payments source 2025-07-03 · Alkermes, Inc. · $48.99 · Open Payments source 2025-07-03 · Alkermes, Inc. · $16.77 · Open Payments source 2025-07-03 · Alkermes, Inc. · $37.09 · Open Payments source 2025-07-03 · Alkermes, Inc. · $1,590.00 · Open Payments source 2025-07-11 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-07-11 · Alkermes, Inc. · $3,635.00 · Open Payments source 2025-07-11 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-07-11 · Alkermes, Inc. · $399.20 · Open Payments source 2025-07-11 · Alkermes, Inc. · $87.41 · Open Payments source 2025-07-11 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-07-11 · Alkermes, Inc. · $10.00 · Open Payments source 2025-07-11 · Alkermes, Inc. · $3,635.00 · Open Payments source 2025-09-23 · Alkermes, Inc. · $386.39 · Open Payments source 2025-10-10 · Alkermes, Inc. · $136.63 · Open Payments source 2025-10-10 · Alkermes, Inc. · $5,900.00 · Open Payments source 2025-10-10 · Alkermes, Inc. · $185.25 · Open Payments source 2025-10-24 · Alkermes, Inc. · $46.30 · Open Payments source 2025-10-24 · Alkermes, Inc. · $44.99 · Open Payments source 2025-10-24 · Alkermes, Inc. · $22.49 · Open Payments source 2025-10-24 · Alkermes, Inc. · $69.11 · Open Payments source 2025-10-24 · Alkermes, Inc. · $22.49 · Open Payments source 2025-10-24 · Alkermes, Inc. · $292.67 · Open Payments source 2025-11-07 · Alkermes, Inc. · $104.17 · Open Payments source 2025-11-20 · Alkermes, Inc. · $50.92 · Open Payments source 2025-11-26 · Alkermes, Inc. · $16.66 · Open Payments source 2025-11-28 · Alkermes, Inc. · $5,900.00 · Open Payments source 2025-11-28 · Alkermes, Inc. · $6,510.00 · Open Payments source
COBENFY Normalized: cobenfy	Drug	E.R. Squibb & Sons, L.L.C.	$96,662.66	92	2025
Source payment records 2025-01-03 · E.R. Squibb & Sons, L.L.C. · $37.18 · Open Payments source 2025-01-03 · E.R. Squibb & Sons, L.L.C. · $34.46 · Open Payments source 2025-01-07 · E.R. Squibb & Sons, L.L.C. · $3,180.00 · Open Payments source 2025-01-09 · E.R. Squibb & Sons, L.L.C. · $19.26 · Open Payments source 2025-01-09 · E.R. Squibb & Sons, L.L.C. · $97.69 · Open Payments source 2025-01-09 · E.R. Squibb & Sons, L.L.C. · $40.67 · Open Payments source 2025-01-09 · E.R. Squibb & Sons, L.L.C. · $30.91 · Open Payments source 2025-01-09 · E.R. Squibb & Sons, L.L.C. · $21.00 · Open Payments source 2025-01-09 · E.R. Squibb & Sons, L.L.C. · $72.00 · Open Payments source 2025-01-09 · E.R. Squibb & Sons, L.L.C. · $134.89 · Open Payments source 2025-01-09 · E.R. Squibb & Sons, L.L.C. · $16.88 · Open Payments source 2025-01-09 · E.R. Squibb & Sons, L.L.C. · $34.17 · Open Payments source 2025-01-09 · E.R. Squibb & Sons, L.L.C. · $53.96 · Open Payments source 2025-01-14 · E.R. Squibb & Sons, L.L.C. · $2,074.00 · Open Payments source 2025-01-14 · E.R. Squibb & Sons, L.L.C. · $6,637.00 · Open Payments source 2025-01-14 · E.R. Squibb & Sons, L.L.C. · $2,765.00 · Open Payments source 2025-01-21 · E.R. Squibb & Sons, L.L.C. · $36.25 · Open Payments source 2025-01-21 · E.R. Squibb & Sons, L.L.C. · $113.90 · Open Payments source 2025-01-21 · E.R. Squibb & Sons, L.L.C. · $77.04 · Open Payments source 2025-01-21 · E.R. Squibb & Sons, L.L.C. · $2,074.00 · Open Payments source 2025-01-21 · E.R. Squibb & Sons, L.L.C. · $40.19 · Open Payments source 2025-01-21 · E.R. Squibb & Sons, L.L.C. · $230.51 · Open Payments source 2025-01-21 · E.R. Squibb & Sons, L.L.C. · $39.70 · Open Payments source 2025-01-21 · E.R. Squibb & Sons, L.L.C. · $253.12 · Open Payments source 2025-01-21 · E.R. Squibb & Sons, L.L.C. · $2,489.00 · Open Payments source 2025-01-28 · E.R. Squibb & Sons, L.L.C. · $28.34 · Open Payments source 2025-03-12 · E.R. Squibb & Sons, L.L.C. · $827.39 · Open Payments source 2025-03-12 · E.R. Squibb & Sons, L.L.C. · $135.00 · Open Payments source 2025-04-03 · E.R. Squibb & Sons, L.L.C. · $6,913.00 · Open Payments source 2025-04-09 · E.R. Squibb & Sons, L.L.C. · $32.49 · Open Payments source 2025-04-09 · E.R. Squibb & Sons, L.L.C. · $171.18 · Open Payments source 2025-04-09 · E.R. Squibb & Sons, L.L.C. · $15.00 · Open Payments source 2025-04-22 · E.R. Squibb & Sons, L.L.C. · $131.18 · Open Payments source 2025-04-22 · E.R. Squibb & Sons, L.L.C. · $133.13 · Open Payments source 2025-04-22 · E.R. Squibb & Sons, L.L.C. · $264.99 · Open Payments source 2025-04-22 · E.R. Squibb & Sons, L.L.C. · $715.42 · Open Payments source 2025-04-23 · E.R. Squibb & Sons, L.L.C. · $353.80 · Open Payments source 2025-05-07 · E.R. Squibb & Sons, L.L.C. · $3,456.00 · Open Payments source 2025-05-07 · E.R. Squibb & Sons, L.L.C. · $6,913.00 · Open Payments source 2025-05-12 · E.R. Squibb & Sons, L.L.C. · $3,180.00 · Open Payments source 2025-05-12 · E.R. Squibb & Sons, L.L.C. · $2,074.00 · Open Payments source 2025-05-18 · E.R. Squibb & Sons, L.L.C. · $28.56 · Open Payments source 2025-05-19 · E.R. Squibb & Sons, L.L.C. · $850.21 · Open Payments source 2025-05-20 · E.R. Squibb & Sons, L.L.C. · $525.13 · Open Payments source 2025-05-21 · E.R. Squibb & Sons, L.L.C. · $125.00 · Open Payments source 2025-05-21 · E.R. Squibb & Sons, L.L.C. · $500.12 · Open Payments source 2025-05-21 · E.R. Squibb & Sons, L.L.C. · $232.15 · Open Payments source 2025-05-27 · E.R. Squibb & Sons, L.L.C. · $462.78 · Open Payments source 2025-06-06 · E.R. Squibb & Sons, L.L.C. · $6,913.00 · Open Payments source 2025-06-10 · E.R. Squibb & Sons, L.L.C. · $2,765.00 · Open Payments source 2025-06-10 · E.R. Squibb & Sons, L.L.C. · $2,765.00 · Open Payments source 2025-06-13 · E.R. Squibb & Sons, L.L.C. · $94.00 · Open Payments source 2025-07-07 · E.R. Squibb & Sons, L.L.C. · $78.51 · Open Payments source 2025-07-07 · E.R. Squibb & Sons, L.L.C. · $2,546.23 · Open Payments source 2025-07-07 · E.R. Squibb & Sons, L.L.C. · $114.95 · Open Payments source 2025-09-04 · E.R. Squibb & Sons, L.L.C. · $111.60 · Open Payments source 2025-09-04 · E.R. Squibb & Sons, L.L.C. · $425.25 · Open Payments source 2025-09-04 · E.R. Squibb & Sons, L.L.C. · $316.08 · Open Payments source 2025-09-23 · E.R. Squibb & Sons, L.L.C. · $6,913.00 · Open Payments source 2025-09-29 · E.R. Squibb & Sons, L.L.C. · $29.04 · Open Payments source 2025-09-29 · E.R. Squibb & Sons, L.L.C. · $146.78 · Open Payments source 2025-10-09 · E.R. Squibb & Sons, L.L.C. · $134.99 · Open Payments source 2025-10-09 · E.R. Squibb & Sons, L.L.C. · $49.99 · Open Payments source 2025-10-09 · E.R. Squibb & Sons, L.L.C. · $29.99 · Open Payments source 2025-10-09 · E.R. Squibb & Sons, L.L.C. · $29.99 · Open Payments source 2025-10-09 · E.R. Squibb & Sons, L.L.C. · $64.99 · Open Payments source 2025-10-09 · E.R. Squibb & Sons, L.L.C. · $29.99 · Open Payments source 2025-10-09 · E.R. Squibb & Sons, L.L.C. · $326.09 · Open Payments source 2025-10-09 · E.R. Squibb & Sons, L.L.C. · $51.73 · Open Payments source 2025-11-10 · E.R. Squibb & Sons, L.L.C. · $83.84 · Open Payments source 2025-11-12 · E.R. Squibb & Sons, L.L.C. · $307.21 · Open Payments source 2025-11-12 · E.R. Squibb & Sons, L.L.C. · $910.23 · Open Payments source 2025-11-12 · E.R. Squibb & Sons, L.L.C. · $546.20 · Open Payments source 2025-11-13 · E.R. Squibb & Sons, L.L.C. · $613.34 · Open Payments source 2025-11-13 · E.R. Squibb & Sons, L.L.C. · $236.13 · Open Payments source 2025-11-13 · E.R. Squibb & Sons, L.L.C. · $654.94 · Open Payments source 2025-11-14 · E.R. Squibb & Sons, L.L.C. · $241.48 · Open Payments source 2025-11-14 · E.R. Squibb & Sons, L.L.C. · $1,605.68 · Open Payments source 2025-12-03 · E.R. Squibb & Sons, L.L.C. · $6,913.00 · Open Payments source 2025-12-04 · E.R. Squibb & Sons, L.L.C. · $2,074.00 · Open Payments source 2025-12-04 · E.R. Squibb & Sons, L.L.C. · $2,489.00 · Open Payments source 2025-12-04 · E.R. Squibb & Sons, L.L.C. · $2,765.00 · Open Payments source 2025-12-08 · E.R. Squibb & Sons, L.L.C. · $14.68 · Open Payments source 2025-12-08 · E.R. Squibb & Sons, L.L.C. · $19.52 · Open Payments source 2025-12-08 · E.R. Squibb & Sons, L.L.C. · $74.04 · Open Payments source 2025-12-16 · E.R. Squibb & Sons, L.L.C. · $480.24 · Open Payments source 2025-12-16 · E.R. Squibb & Sons, L.L.C. · $483.32 · Open Payments source 2025-12-16 · E.R. Squibb & Sons, L.L.C. · $1,370.97 · Open Payments source 2025-12-17 · E.R. Squibb & Sons, L.L.C. · $773.95 · Open Payments source 2025-12-17 · E.R. Squibb & Sons, L.L.C. · $664.93 · Open Payments source 2025-12-18 · E.R. Squibb & Sons, L.L.C. · $115.34 · Open Payments source 2025-12-18 · E.R. Squibb & Sons, L.L.C. · $618.77 · Open Payments source
REXULTI Normalized: rexulti	Drug	Otsuka America Pharmaceutical, Inc., Otsuka Pharmaceutical Development & Commercialization, Inc.	$96,160.86	116	2025
Source payment records 2025-01-21 · Otsuka America Pharmaceutical, Inc. · $273.99 · Open Payments source 2025-01-22 · Otsuka America Pharmaceutical, Inc. · $273.99 · Open Payments source 2025-01-23 · Otsuka America Pharmaceutical, Inc. · $273.99 · Open Payments source 2025-01-24 · Otsuka America Pharmaceutical, Inc. · $859.93 · Open Payments source 2025-01-25 · Otsuka America Pharmaceutical, Inc. · $4,752.00 · Open Payments source 2025-01-29 · Otsuka America Pharmaceutical, Inc. · $4,752.00 · Open Payments source 2025-01-29 · Otsuka America Pharmaceutical, Inc. · $3,456.00 · Open Payments source 2025-02-01 · Otsuka America Pharmaceutical, Inc. · $41.79 · Open Payments source 2025-02-01 · Otsuka America Pharmaceutical, Inc. · $19.04 · Open Payments source 2025-02-01 · Otsuka America Pharmaceutical, Inc. · $31.43 · Open Payments source 2025-02-01 · Otsuka America Pharmaceutical, Inc. · $18.17 · Open Payments source 2025-02-01 · Otsuka America Pharmaceutical, Inc. · $40.72 · Open Payments source 2025-02-04 · Otsuka Pharmaceutical Development & Commercialization, Inc. · $3,780.00 · Open Payments source 2025-02-12 · Otsuka America Pharmaceutical, Inc. · $16.25 · Open Payments source 2025-02-12 · Otsuka America Pharmaceutical, Inc. · $268.15 · Open Payments source 2025-02-12 · Otsuka America Pharmaceutical, Inc. · $47.93 · Open Payments source 2025-02-12 · Otsuka America Pharmaceutical, Inc. · $38.52 · Open Payments source 2025-02-12 · Otsuka America Pharmaceutical, Inc. · $20.00 · Open Payments source 2025-02-12 · Otsuka America Pharmaceutical, Inc. · $23.54 · Open Payments source 2025-02-12 · Otsuka America Pharmaceutical, Inc. · $23.80 · Open Payments source 2025-02-12 · Otsuka America Pharmaceutical, Inc. · $18.02 · Open Payments source 2025-02-12 · Otsuka America Pharmaceutical, Inc. · $50.00 · Open Payments source 2025-04-18 · Otsuka America Pharmaceutical, Inc. · $351.00 · Open Payments source 2025-05-06 · Otsuka America Pharmaceutical, Inc. · $87.99 · Open Payments source 2025-05-06 · Otsuka America Pharmaceutical, Inc. · $87.99 · Open Payments source 2025-05-07 · Otsuka America Pharmaceutical, Inc. · $87.99 · Open Payments source 2025-05-07 · Otsuka America Pharmaceutical, Inc. · $87.99 · Open Payments source 2025-05-09 · Otsuka America Pharmaceutical, Inc. · $254.61 · Open Payments source 2025-05-09 · Otsuka America Pharmaceutical, Inc. · $4,752.00 · Open Payments source 2025-05-09 · Otsuka America Pharmaceutical, Inc. · $254.60 · Open Payments source 2025-05-09 · Otsuka America Pharmaceutical, Inc. · $4,104.00 · Open Payments source 2025-05-09 · Otsuka America Pharmaceutical, Inc. · $254.60 · Open Payments source 2025-05-09 · Otsuka America Pharmaceutical, Inc. · $254.60 · Open Payments source 2025-05-09 · Otsuka America Pharmaceutical, Inc. · $3,456.00 · Open Payments source 2025-05-14 · Otsuka America Pharmaceutical, Inc. · $3,456.00 · Open Payments source 2025-05-21 · Otsuka America Pharmaceutical, Inc. · $25.00 · Open Payments source 2025-05-21 · Otsuka America Pharmaceutical, Inc. · $25.00 · Open Payments source 2025-05-21 · Otsuka America Pharmaceutical, Inc. · $4.27 · Open Payments source 2025-05-21 · Otsuka America Pharmaceutical, Inc. · $27.32 · Open Payments source 2025-05-21 · Otsuka America Pharmaceutical, Inc. · $227.25 · Open Payments source 2025-05-21 · Otsuka America Pharmaceutical, Inc. · $150.00 · Open Payments source 2025-05-21 · Otsuka America Pharmaceutical, Inc. · $6.66 · Open Payments source 2025-05-21 · Otsuka America Pharmaceutical, Inc. · $43.42 · Open Payments source 2025-06-10 · Otsuka America Pharmaceutical, Inc. · $105.70 · Open Payments source 2025-06-10 · Otsuka America Pharmaceutical, Inc. · $105.69 · Open Payments source 2025-06-11 · Otsuka America Pharmaceutical, Inc. · $105.69 · Open Payments source 2025-06-11 · Otsuka America Pharmaceutical, Inc. · $105.69 · Open Payments source 2025-06-12 · Otsuka America Pharmaceutical, Inc. · $1,003.41 · Open Payments source 2025-06-12 · Otsuka America Pharmaceutical, Inc. · $105.70 · Open Payments source 2025-06-12 · Otsuka America Pharmaceutical, Inc. · $125.00 · Open Payments source 2025-06-12 · Otsuka America Pharmaceutical, Inc. · $105.70 · Open Payments source 2025-06-14 · Otsuka America Pharmaceutical, Inc. · $3,456.00 · Open Payments source 2025-06-18 · Otsuka America Pharmaceutical, Inc. · $4,104.00 · Open Payments source 2025-06-18 · Otsuka America Pharmaceutical, Inc. · $4,752.00 · Open Payments source 2025-06-18 · Otsuka America Pharmaceutical, Inc. · $2,808.00 · Open Payments source 2025-06-18 · Otsuka America Pharmaceutical, Inc. · $3,456.00 · Open Payments source 2025-06-18 · Otsuka America Pharmaceutical, Inc. · $3,456.00 · Open Payments source 2025-06-23 · Otsuka America Pharmaceutical, Inc. · $22.02 · Open Payments source 2025-06-23 · Otsuka America Pharmaceutical, Inc. · $25.00 · Open Payments source 2025-06-23 · Otsuka America Pharmaceutical, Inc. · $32.55 · Open Payments source 2025-06-23 · Otsuka America Pharmaceutical, Inc. · $23.14 · Open Payments source 2025-06-23 · Otsuka America Pharmaceutical, Inc. · $25.00 · Open Payments source 2025-06-23 · Otsuka America Pharmaceutical, Inc. · $35.73 · Open Payments source 2025-06-23 · Otsuka America Pharmaceutical, Inc. · $24.11 · Open Payments source 2025-06-23 · Otsuka America Pharmaceutical, Inc. · $20.14 · Open Payments source 2025-06-23 · Otsuka America Pharmaceutical, Inc. · $14.34 · Open Payments source 2025-06-23 · Otsuka America Pharmaceutical, Inc. · $10.78 · Open Payments source 2025-06-23 · Otsuka America Pharmaceutical, Inc. · $239.98 · Open Payments source 2025-06-23 · Otsuka America Pharmaceutical, Inc. · $2.96 · Open Payments source 2025-06-25 · Otsuka America Pharmaceutical, Inc. · $37.05 · Open Payments source 2025-07-08 · Otsuka America Pharmaceutical, Inc. · $93.00 · Open Payments source 2025-07-08 · Otsuka America Pharmaceutical, Inc. · $93.00 · Open Payments source 2025-07-09 · Otsuka America Pharmaceutical, Inc. · $93.00 · Open Payments source 2025-07-09 · Otsuka America Pharmaceutical, Inc. · $92.99 · Open Payments source 2025-07-10 · Otsuka America Pharmaceutical, Inc. · $120.06 · Open Payments source 2025-07-10 · Otsuka America Pharmaceutical, Inc. · $92.99 · Open Payments source 2025-07-10 · Otsuka America Pharmaceutical, Inc. · $120.06 · Open Payments source 2025-07-10 · Otsuka America Pharmaceutical, Inc. · $120.06 · Open Payments source 2025-07-10 · Otsuka America Pharmaceutical, Inc. · $120.06 · Open Payments source 2025-07-10 · Otsuka America Pharmaceutical, Inc. · $120.07 · Open Payments source 2025-07-10 · Otsuka America Pharmaceutical, Inc. · $568.03 · Open Payments source 2025-07-11 · Otsuka America Pharmaceutical, Inc. · $3,456.00 · Open Payments source 2025-07-16 · Otsuka America Pharmaceutical, Inc. · $3,456.00 · Open Payments source 2025-07-16 · Otsuka America Pharmaceutical, Inc. · $4,104.00 · Open Payments source 2025-07-16 · Otsuka America Pharmaceutical, Inc. · $4,104.00 · Open Payments source 2025-07-30 · Otsuka America Pharmaceutical, Inc. · $86.22 · Open Payments source 2025-07-30 · Otsuka America Pharmaceutical, Inc. · $19.70 · Open Payments source 2025-07-30 · Otsuka America Pharmaceutical, Inc. · $25.00 · Open Payments source 2025-07-30 · Otsuka America Pharmaceutical, Inc. · $4.09 · Open Payments source 2025-07-30 · Otsuka America Pharmaceutical, Inc. · $12.91 · Open Payments source 2025-07-30 · Otsuka America Pharmaceutical, Inc. · $12.96 · Open Payments source 2025-07-30 · Otsuka America Pharmaceutical, Inc. · $20.88 · Open Payments source 2025-07-30 · Otsuka America Pharmaceutical, Inc. · $43.53 · Open Payments source 2025-07-30 · Otsuka America Pharmaceutical, Inc. · $78.13 · Open Payments source 2025-07-30 · Otsuka America Pharmaceutical, Inc. · $96.53 · Open Payments source 2025-07-30 · Otsuka America Pharmaceutical, Inc. · $24.77 · Open Payments source 2025-07-30 · Otsuka America Pharmaceutical, Inc. · $24.62 · Open Payments source 2025-08-13 · Otsuka America Pharmaceutical, Inc. · $3,456.00 · Open Payments source 2025-08-20 · Otsuka America Pharmaceutical, Inc. · $10.92 · Open Payments source 2025-08-20 · Otsuka America Pharmaceutical, Inc. · $112.64 · Open Payments source 2025-08-20 · Otsuka America Pharmaceutical, Inc. · $13.96 · Open Payments source 2025-08-20 · Otsuka America Pharmaceutical, Inc. · $90.77 · Open Payments source 2025-08-20 · Otsuka America Pharmaceutical, Inc. · $25.00 · Open Payments source 2025-08-20 · Otsuka America Pharmaceutical, Inc. · $25.00 · Open Payments source 2025-08-20 · Otsuka America Pharmaceutical, Inc. · $356.58 · Open Payments source 2025-08-29 · Otsuka America Pharmaceutical, Inc. · $15.96 · Open Payments source 2025-08-29 · Otsuka America Pharmaceutical, Inc. · $18.75 · Open Payments source 2025-08-29 · Otsuka America Pharmaceutical, Inc. · $21.24 · Open Payments source 2025-10-06 · Otsuka America Pharmaceutical, Inc. · $171.98 · Open Payments source 2025-10-07 · Otsuka America Pharmaceutical, Inc. · $171.99 · Open Payments source 2025-10-07 · Otsuka America Pharmaceutical, Inc. · $430.78 · Open Payments source 2025-10-10 · Otsuka America Pharmaceutical, Inc. · $2,160.00 · Open Payments source 2025-10-10 · Otsuka America Pharmaceutical, Inc. · $493.85 · Open Payments source 2025-10-10 · Otsuka America Pharmaceutical, Inc. · $493.85 · Open Payments source 2025-10-10 · Otsuka America Pharmaceutical, Inc. · $4,752.00 · Open Payments source 2025-10-24 · Otsuka America Pharmaceutical, Inc. · $4,752.00 · Open Payments source
AUSTEDO XR Normalized: austedo xr	Drug	Teva Pharmaceuticals USA, Inc.	$76,616.20	68	2025
Source payment records 2025-03-09 · Teva Pharmaceuticals USA, Inc. · $47.58 · Open Payments source 2025-04-08 · Teva Pharmaceuticals USA, Inc. · $48.40 · Open Payments source 2025-04-08 · Teva Pharmaceuticals USA, Inc. · $151.30 · Open Payments source 2025-04-08 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source 2025-04-08 · Teva Pharmaceuticals USA, Inc. · $64.07 · Open Payments source 2025-04-08 · Teva Pharmaceuticals USA, Inc. · $151.32 · Open Payments source 2025-04-08 · Teva Pharmaceuticals USA, Inc. · $571.36 · Open Payments source 2025-04-08 · Teva Pharmaceuticals USA, Inc. · $5,526.00 · Open Payments source 2025-04-08 · Teva Pharmaceuticals USA, Inc. · $41.32 · Open Payments source 2025-04-09 · Teva Pharmaceuticals USA, Inc. · $10.48 · Open Payments source 2025-04-09 · Teva Pharmaceuticals USA, Inc. · $55.95 · Open Payments source 2025-04-09 · Teva Pharmaceuticals USA, Inc. · $151.30 · Open Payments source 2025-04-09 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source 2025-04-09 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source 2025-04-09 · Teva Pharmaceuticals USA, Inc. · $151.30 · Open Payments source 2025-04-09 · Teva Pharmaceuticals USA, Inc. · $22.02 · Open Payments source 2025-04-10 · Teva Pharmaceuticals USA, Inc. · $12.44 · Open Payments source 2025-04-10 · Teva Pharmaceuticals USA, Inc. · $51.97 · Open Payments source 2025-04-10 · Teva Pharmaceuticals USA, Inc. · $151.30 · Open Payments source 2025-04-10 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source 2025-04-10 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source 2025-04-10 · Teva Pharmaceuticals USA, Inc. · $151.30 · Open Payments source 2025-04-10 · Teva Pharmaceuticals USA, Inc. · $392.26 · Open Payments source 2025-04-15 · Teva Pharmaceuticals USA, Inc. · $53.17 · Open Payments source 2025-04-15 · Teva Pharmaceuticals USA, Inc. · $109.70 · Open Payments source 2025-04-15 · Teva Pharmaceuticals USA, Inc. · $211.01 · Open Payments source 2025-04-15 · Teva Pharmaceuticals USA, Inc. · $5,527.00 · Open Payments source 2025-04-15 · Teva Pharmaceuticals USA, Inc. · $41.26 · Open Payments source 2025-04-16 · Teva Pharmaceuticals USA, Inc. · $63.11 · Open Payments source 2025-04-16 · Teva Pharmaceuticals USA, Inc. · $109.72 · Open Payments source 2025-04-16 · Teva Pharmaceuticals USA, Inc. · $211.01 · Open Payments source 2025-04-16 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source 2025-05-13 · Teva Pharmaceuticals USA, Inc. · $15.48 · Open Payments source 2025-05-13 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source 2025-05-14 · Teva Pharmaceuticals USA, Inc. · $29.18 · Open Payments source 2025-05-14 · Teva Pharmaceuticals USA, Inc. · $62.14 · Open Payments source 2025-05-14 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source 2025-05-14 · Teva Pharmaceuticals USA, Inc. · $5,527.00 · Open Payments source 2025-05-14 · Teva Pharmaceuticals USA, Inc. · $146.22 · Open Payments source 2025-05-14 · Teva Pharmaceuticals USA, Inc. · $17.95 · Open Payments source 2025-05-17 · Teva Pharmaceuticals USA, Inc. · $334.47 · Open Payments source 2025-05-17 · Teva Pharmaceuticals USA, Inc. · $555.94 · Open Payments source 2025-05-17 · Teva Pharmaceuticals USA, Inc. · $6,176.00 · Open Payments source 2025-06-13 · Teva Pharmaceuticals USA, Inc. · $1,470.00 · Open Payments source 2025-08-29 · Teva Pharmaceuticals USA, Inc. · $6,615.00 · Open Payments source 2025-08-29 · Teva Pharmaceuticals USA, Inc. · $705.00 · Open Payments source 2025-11-03 · Teva Pharmaceuticals USA, Inc. · $5,880.00 · Open Payments source 2025-12-02 · Teva Pharmaceuticals USA, Inc. · $27.81 · Open Payments source 2025-12-02 · Teva Pharmaceuticals USA, Inc. · $48.96 · Open Payments source 2025-12-02 · Teva Pharmaceuticals USA, Inc. · $2.60 · Open Payments source 2025-12-02 · Teva Pharmaceuticals USA, Inc. · $31.15 · Open Payments source 2025-12-02 · Teva Pharmaceuticals USA, Inc. · $124.85 · Open Payments source 2025-12-02 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source 2025-12-02 · Teva Pharmaceuticals USA, Inc. · $5,526.00 · Open Payments source 2025-12-02 · Teva Pharmaceuticals USA, Inc. · $2.60 · Open Payments source 2025-12-02 · Teva Pharmaceuticals USA, Inc. · $31.15 · Open Payments source 2025-12-02 · Teva Pharmaceuticals USA, Inc. · $124.85 · Open Payments source 2025-12-02 · Teva Pharmaceuticals USA, Inc. · $53.97 · Open Payments source 2025-12-03 · Teva Pharmaceuticals USA, Inc. · $38.51 · Open Payments source 2025-12-03 · Teva Pharmaceuticals USA, Inc. · $61.47 · Open Payments source 2025-12-03 · Teva Pharmaceuticals USA, Inc. · $2.60 · Open Payments source 2025-12-03 · Teva Pharmaceuticals USA, Inc. · $31.15 · Open Payments source 2025-12-03 · Teva Pharmaceuticals USA, Inc. · $44.20 · Open Payments source 2025-12-03 · Teva Pharmaceuticals USA, Inc. · $124.85 · Open Payments source 2025-12-03 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source 2025-12-03 · Teva Pharmaceuticals USA, Inc. · $2.60 · Open Payments source 2025-12-03 · Teva Pharmaceuticals USA, Inc. · $124.85 · Open Payments source 2025-12-03 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source
FANAPT Normalized: fanapt	Drug	Vanda Pharmaceuticals Inc.	$65,513.06	66	2025
Source payment records 2025-02-04 · Vanda Pharmaceuticals Inc. · $3,900.00 · Open Payments source 2025-02-04 · Vanda Pharmaceuticals Inc. · $37.09 · Open Payments source 2025-03-10 · Vanda Pharmaceuticals Inc. · $3,380.00 · Open Payments source 2025-03-10 · Vanda Pharmaceuticals Inc. · $34.37 · Open Payments source 2025-03-10 · Vanda Pharmaceuticals Inc. · $13.62 · Open Payments source 2025-04-14 · Vanda Pharmaceuticals Inc. · $3,900.00 · Open Payments source 2025-04-14 · Vanda Pharmaceuticals Inc. · $20.02 · Open Payments source 2025-04-14 · Vanda Pharmaceuticals Inc. · $34.23 · Open Payments source 2025-05-08 · Vanda Pharmaceuticals Inc. · $3,900.00 · Open Payments source 2025-05-08 · Vanda Pharmaceuticals Inc. · $315.48 · Open Payments source 2025-05-08 · Vanda Pharmaceuticals Inc. · $279.49 · Open Payments source 2025-05-08 · Vanda Pharmaceuticals Inc. · $125.75 · Open Payments source 2025-05-08 · Vanda Pharmaceuticals Inc. · $57.47 · Open Payments source 2025-05-12 · Vanda Pharmaceuticals Inc. · $40.00 · Open Payments source 2025-06-23 · Vanda Pharmaceuticals Inc. · $3,900.00 · Open Payments source 2025-06-23 · Vanda Pharmaceuticals Inc. · $48.58 · Open Payments source 2025-06-23 · Vanda Pharmaceuticals Inc. · $38.27 · Open Payments source 2025-06-30 · Vanda Pharmaceuticals Inc. · $2,600.00 · Open Payments source 2025-06-30 · Vanda Pharmaceuticals Inc. · $450.48 · Open Payments source 2025-06-30 · Vanda Pharmaceuticals Inc. · $23.94 · Open Payments source 2025-06-30 · Vanda Pharmaceuticals Inc. · $2,600.00 · Open Payments source 2025-06-30 · Vanda Pharmaceuticals Inc. · $450.48 · Open Payments source 2025-06-30 · Vanda Pharmaceuticals Inc. · $49.11 · Open Payments source 2025-07-21 · Vanda Pharmaceuticals Inc. · $3,380.00 · Open Payments source 2025-07-21 · Vanda Pharmaceuticals Inc. · $265.30 · Open Payments source 2025-07-21 · Vanda Pharmaceuticals Inc. · $48.47 · Open Payments source 2025-07-28 · Vanda Pharmaceuticals Inc. · $3,380.00 · Open Payments source 2025-07-28 · Vanda Pharmaceuticals Inc. · $40.12 · Open Payments source 2025-07-28 · Vanda Pharmaceuticals Inc. · $2,600.00 · Open Payments source 2025-07-28 · Vanda Pharmaceuticals Inc. · $65.00 · Open Payments source 2025-07-28 · Vanda Pharmaceuticals Inc. · $207.20 · Open Payments source 2025-07-28 · Vanda Pharmaceuticals Inc. · $32.30 · Open Payments source 2025-08-11 · Vanda Pharmaceuticals Inc. · $2,600.00 · Open Payments source 2025-08-11 · Vanda Pharmaceuticals Inc. · $110.79 · Open Payments source 2025-08-11 · Vanda Pharmaceuticals Inc. · $182.70 · Open Payments source 2025-08-11 · Vanda Pharmaceuticals Inc. · $37.99 · Open Payments source 2025-08-11 · Vanda Pharmaceuticals Inc. · $3,380.00 · Open Payments source 2025-08-11 · Vanda Pharmaceuticals Inc. · $110.79 · Open Payments source 2025-08-11 · Vanda Pharmaceuticals Inc. · $5.00 · Open Payments source 2025-08-11 · Vanda Pharmaceuticals Inc. · $4.41 · Open Payments source 2025-08-15 · Vanda Pharmaceuticals Inc. · $178.12 · Open Payments source 2025-08-15 · Vanda Pharmaceuticals Inc. · $212.50 · Open Payments source 2025-08-15 · Vanda Pharmaceuticals Inc. · $7,020.00 · Open Payments source 2025-08-15 · Vanda Pharmaceuticals Inc. · $16.46 · Open Payments source 2025-08-15 · Vanda Pharmaceuticals Inc. · $823.35 · Open Payments source 2025-08-15 · Vanda Pharmaceuticals Inc. · $219.22 · Open Payments source 2025-08-15 · Vanda Pharmaceuticals Inc. · $40.97 · Open Payments source 2025-08-16 · Vanda Pharmaceuticals Inc. · $2.66 · Open Payments source 2025-08-16 · Vanda Pharmaceuticals Inc. · $79.73 · Open Payments source 2025-08-16 · Vanda Pharmaceuticals Inc. · $3.99 · Open Payments source 2025-08-16 · Vanda Pharmaceuticals Inc. · $29.52 · Open Payments source 2025-08-16 · Vanda Pharmaceuticals Inc. · $69.90 · Open Payments source 2025-08-16 · Vanda Pharmaceuticals Inc. · $32.61 · Open Payments source 2025-08-16 · Vanda Pharmaceuticals Inc. · $49.55 · Open Payments source 2025-10-20 · Vanda Pharmaceuticals Inc. · $3,900.00 · Open Payments source 2025-10-20 · Vanda Pharmaceuticals Inc. · $208.60 · Open Payments source 2025-10-20 · Vanda Pharmaceuticals Inc. · $14.83 · Open Payments source 2025-10-20 · Vanda Pharmaceuticals Inc. · $3,380.00 · Open Payments source 2025-10-20 · Vanda Pharmaceuticals Inc. · $38.00 · Open Payments source 2025-11-11 · Vanda Pharmaceuticals Inc. · $2,600.00 · Open Payments source 2025-11-11 · Vanda Pharmaceuticals Inc. · $32.50 · Open Payments source 2025-11-11 · Vanda Pharmaceuticals Inc. · $359.46 · Open Payments source 2025-11-11 · Vanda Pharmaceuticals Inc. · $19.88 · Open Payments source 2025-11-11 · Vanda Pharmaceuticals Inc. · $3,380.00 · Open Payments source 2025-11-11 · Vanda Pharmaceuticals Inc. · $32.50 · Open Payments source 2025-11-11 · Vanda Pharmaceuticals Inc. · $120.26 · Open Payments source
ARISTADA Normalized: aristada	Drug	Alkermes, Inc.	$38,891.04	45	2025
Source payment records 2025-01-28 · Alkermes, Inc. · $303.97 · Open Payments source 2025-01-28 · Alkermes, Inc. · $356.80 · Open Payments source 2025-06-06 · Alkermes, Inc. · $827.97 · Open Payments source 2025-06-06 · Alkermes, Inc. · $266.96 · Open Payments source 2025-06-06 · Alkermes, Inc. · $91.06 · Open Payments source 2025-06-06 · Alkermes, Inc. · $72.14 · Open Payments source 2025-06-06 · Alkermes, Inc. · $32.37 · Open Payments source 2025-06-06 · Alkermes, Inc. · $27.15 · Open Payments source 2025-06-06 · Alkermes, Inc. · $14.67 · Open Payments source 2025-06-06 · Alkermes, Inc. · $12.14 · Open Payments source 2025-06-06 · Alkermes, Inc. · $179.61 · Open Payments source 2025-06-06 · Alkermes, Inc. · $31.37 · Open Payments source 2025-06-06 · Alkermes, Inc. · $7.11 · Open Payments source 2025-06-18 · Alkermes, Inc. · $1,590.00 · Open Payments source 2025-07-03 · Alkermes, Inc. · $68.62 · Open Payments source 2025-07-10 · Alkermes, Inc. · $7,720.00 · Open Payments source 2025-07-11 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-07-25 · Alkermes, Inc. · $48.26 · Open Payments source 2025-07-25 · Alkermes, Inc. · $63.95 · Open Payments source 2025-10-24 · Alkermes, Inc. · $46.30 · Open Payments source 2025-10-24 · Alkermes, Inc. · $44.99 · Open Payments source 2025-10-24 · Alkermes, Inc. · $22.49 · Open Payments source 2025-10-24 · Alkermes, Inc. · $69.11 · Open Payments source 2025-10-24 · Alkermes, Inc. · $22.49 · Open Payments source 2025-10-24 · Alkermes, Inc. · $292.67 · Open Payments source 2025-10-28 · Alkermes, Inc. · $139.48 · Open Payments source 2025-10-28 · Alkermes, Inc. · $533.56 · Open Payments source 2025-11-07 · Alkermes, Inc. · $104.17 · Open Payments source 2025-11-14 · Alkermes, Inc. · $5,900.00 · Open Payments source 2025-11-14 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-11-14 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-11-14 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-11-14 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-11-20 · Alkermes, Inc. · $50.92 · Open Payments source 2025-11-26 · Alkermes, Inc. · $18.76 · Open Payments source 2025-11-26 · Alkermes, Inc. · $42.95 · Open Payments source 2025-11-26 · Alkermes, Inc. · $36.74 · Open Payments source 2025-11-26 · Alkermes, Inc. · $9.63 · Open Payments source 2025-11-26 · Alkermes, Inc. · $49.96 · Open Payments source 2025-11-26 · Alkermes, Inc. · $31.73 · Open Payments source 2025-11-28 · Alkermes, Inc. · $6,510.00 · Open Payments source 2025-12-15 · Alkermes, Inc. · $54.00 · Open Payments source 2025-12-15 · Alkermes, Inc. · $293.95 · Open Payments source 2025-12-15 · Alkermes, Inc. · $81.16 · Open Payments source 2025-12-15 · Alkermes, Inc. · $321.83 · Open Payments source
SPRAVATO Normalized: spravato	Drug	Janssen Global Services, LLC, Janssen Pharmaceuticals, Inc, Janssen Scientific Affairs, LLC	$37,331.11	41	2025
Source payment records 2025-02-03 · Janssen Pharmaceuticals, Inc · $877.50 · Open Payments source 2025-02-03 · Janssen Pharmaceuticals, Inc · $2,925.00 · Open Payments source 2025-02-05 · Janssen Pharmaceuticals, Inc · $75.78 · Open Payments source 2025-02-05 · Janssen Pharmaceuticals, Inc · $266.46 · Open Payments source 2025-02-05 · Janssen Pharmaceuticals, Inc · $550.13 · Open Payments source 2025-02-06 · Janssen Pharmaceuticals, Inc · $178.22 · Open Payments source 2025-02-06 · Janssen Pharmaceuticals, Inc · $20.23 · Open Payments source 2025-02-07 · Janssen Pharmaceuticals, Inc · $14.71 · Open Payments source 2025-02-07 · Janssen Pharmaceuticals, Inc · $13.92 · Open Payments source 2025-02-07 · Janssen Pharmaceuticals, Inc · $50.00 · Open Payments source 2025-02-07 · Janssen Pharmaceuticals, Inc · $120.44 · Open Payments source 2025-02-07 · Janssen Pharmaceuticals, Inc · $9.80 · Open Payments source 2025-02-07 · Janssen Pharmaceuticals, Inc · $33.33 · Open Payments source 2025-02-08 · Janssen Pharmaceuticals, Inc · $17.63 · Open Payments source 2025-02-08 · Janssen Pharmaceuticals, Inc · $12.70 · Open Payments source 2025-02-08 · Janssen Pharmaceuticals, Inc · $35.79 · Open Payments source 2025-02-08 · Janssen Pharmaceuticals, Inc · $56.57 · Open Payments source 2025-02-08 · Janssen Pharmaceuticals, Inc · $13.68 · Open Payments source 2025-02-08 · Janssen Pharmaceuticals, Inc · $49.97 · Open Payments source 2025-05-01 · Janssen Pharmaceuticals, Inc · $12,285.00 · Open Payments source 2025-05-15 · Janssen Global Services, LLC · $15.64 · Open Payments source 2025-05-15 · Janssen Global Services, LLC · $75.78 · Open Payments source 2025-05-16 · Janssen Global Services, LLC · $365.61 · Open Payments source 2025-05-16 · Janssen Global Services, LLC · $31.18 · Open Payments source 2025-05-16 · Janssen Global Services, LLC · $7,762.50 · Open Payments source 2025-05-16 · Janssen Global Services, LLC · $46.77 · Open Payments source 2025-05-16 · Janssen Global Services, LLC · $21.33 · Open Payments source 2025-07-31 · Janssen Scientific Affairs, LLC · $705.00 · Open Payments source 2025-10-14 · Janssen Global Services, LLC · $29.98 · Open Payments source 2025-10-14 · Janssen Global Services, LLC · $82.41 · Open Payments source 2025-10-14 · Janssen Global Services, LLC · $34.27 · Open Payments source 2025-10-14 · Janssen Pharmaceuticals, Inc · $4,145.00 · Open Payments source 2025-10-15 · Janssen Global Services, LLC · $22.66 · Open Payments source 2025-10-15 · Janssen Global Services, LLC · $13.39 · Open Payments source 2025-10-15 · Janssen Global Services, LLC · $42.28 · Open Payments source 2025-10-15 · Janssen Global Services, LLC · $5,400.00 · Open Payments source 2025-10-15 · Janssen Global Services, LLC · $16.63 · Open Payments source 2025-10-15 · Janssen Global Services, LLC · $411.97 · Open Payments source 2025-10-16 · Janssen Global Services, LLC · $411.97 · Open Payments source 2025-10-16 · Janssen Global Services, LLC · $16.63 · Open Payments source 2025-10-16 · Janssen Global Services, LLC · $73.25 · Open Payments source
UZEDY Normalized: uzedy	Drug	Teva Pharmaceuticals USA, Inc.	$36,014.28	20	2025
Source payment records 2025-04-07 · Teva Pharmaceuticals USA, Inc. · $14,057.00 · Open Payments source 2025-04-16 · Teva Pharmaceuticals USA, Inc. · $4.27 · Open Payments source 2025-04-16 · Teva Pharmaceuticals USA, Inc. · $109.72 · Open Payments source 2025-04-16 · Teva Pharmaceuticals USA, Inc. · $211.01 · Open Payments source 2025-04-16 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source 2025-04-17 · Teva Pharmaceuticals USA, Inc. · $73.77 · Open Payments source 2025-04-17 · Teva Pharmaceuticals USA, Inc. · $95.89 · Open Payments source 2025-04-17 · Teva Pharmaceuticals USA, Inc. · $105.22 · Open Payments source 2025-04-17 · Teva Pharmaceuticals USA, Inc. · $109.72 · Open Payments source 2025-04-17 · Teva Pharmaceuticals USA, Inc. · $211.01 · Open Payments source 2025-04-17 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source 2025-04-17 · Teva Pharmaceuticals USA, Inc. · $211.01 · Open Payments source 2025-04-17 · Teva Pharmaceuticals USA, Inc. · $2,600.00 · Open Payments source 2025-04-17 · Teva Pharmaceuticals USA, Inc. · $187.34 · Open Payments source 2025-04-17 · Teva Pharmaceuticals USA, Inc. · $54.59 · Open Payments source 2025-10-20 · Teva Pharmaceuticals USA, Inc. · $5,880.00 · Open Payments source 2025-10-20 · Teva Pharmaceuticals USA, Inc. · $82.23 · Open Payments source 2025-10-20 · Teva Pharmaceuticals USA, Inc. · $5,512.50 · Open Payments source 2025-12-07 · Teva Pharmaceuticals USA, Inc. · $574.00 · Open Payments source 2025-12-23 · Teva Pharmaceuticals USA, Inc. · $735.00 · Open Payments source
ARISTADA INITIO Normalized: aristada initio	Drug	Alkermes, Inc.	$31,067.13	34	2025
Source payment records 2025-06-06 · Alkermes, Inc. · $827.97 · Open Payments source 2025-06-06 · Alkermes, Inc. · $266.96 · Open Payments source 2025-06-06 · Alkermes, Inc. · $91.06 · Open Payments source 2025-06-06 · Alkermes, Inc. · $72.14 · Open Payments source 2025-06-06 · Alkermes, Inc. · $32.37 · Open Payments source 2025-06-06 · Alkermes, Inc. · $27.15 · Open Payments source 2025-06-06 · Alkermes, Inc. · $14.67 · Open Payments source 2025-06-06 · Alkermes, Inc. · $12.14 · Open Payments source 2025-06-06 · Alkermes, Inc. · $179.61 · Open Payments source 2025-06-06 · Alkermes, Inc. · $31.37 · Open Payments source 2025-06-06 · Alkermes, Inc. · $7.11 · Open Payments source 2025-06-18 · Alkermes, Inc. · $1,590.00 · Open Payments source 2025-07-03 · Alkermes, Inc. · $68.62 · Open Payments source 2025-07-10 · Alkermes, Inc. · $7,720.00 · Open Payments source 2025-07-11 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-07-25 · Alkermes, Inc. · $48.26 · Open Payments source 2025-07-25 · Alkermes, Inc. · $63.95 · Open Payments source 2025-10-28 · Alkermes, Inc. · $139.48 · Open Payments source 2025-10-28 · Alkermes, Inc. · $533.56 · Open Payments source 2025-11-14 · Alkermes, Inc. · $5,900.00 · Open Payments source 2025-11-14 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-11-14 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-11-14 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-11-14 · Alkermes, Inc. · $2,500.00 · Open Payments source 2025-11-26 · Alkermes, Inc. · $18.76 · Open Payments source 2025-11-26 · Alkermes, Inc. · $42.95 · Open Payments source 2025-11-26 · Alkermes, Inc. · $36.74 · Open Payments source 2025-11-26 · Alkermes, Inc. · $9.63 · Open Payments source 2025-11-26 · Alkermes, Inc. · $49.96 · Open Payments source 2025-11-26 · Alkermes, Inc. · $31.73 · Open Payments source 2025-12-15 · Alkermes, Inc. · $54.00 · Open Payments source 2025-12-15 · Alkermes, Inc. · $293.95 · Open Payments source 2025-12-15 · Alkermes, Inc. · $81.16 · Open Payments source 2025-12-15 · Alkermes, Inc. · $321.83 · Open Payments source
Qelbree Normalized: qelbree	Drug	Supernus Pharmaceuticals, Inc.	$25,479.88	27	2025
Source payment records 2025-04-11 · Supernus Pharmaceuticals, Inc. · $1,710.00 · Open Payments source 2025-04-11 · Supernus Pharmaceuticals, Inc. · $570.00 · Open Payments source 2025-04-11 · Supernus Pharmaceuticals, Inc. · $44.46 · Open Payments source 2025-05-02 · Supernus Pharmaceuticals, Inc. · $448.21 · Open Payments source 2025-05-02 · Supernus Pharmaceuticals, Inc. · $393.76 · Open Payments source 2025-05-02 · Supernus Pharmaceuticals, Inc. · $203.34 · Open Payments source 2025-05-02 · Supernus Pharmaceuticals, Inc. · $430.00 · Open Payments source 2025-05-02 · Supernus Pharmaceuticals, Inc. · $5,500.00 · Open Payments source 2025-05-03 · Supernus Pharmaceuticals, Inc. · $14.10 · Open Payments source 2025-05-03 · Supernus Pharmaceuticals, Inc. · $34.44 · Open Payments source 2025-05-03 · Supernus Pharmaceuticals, Inc. · $84.46 · Open Payments source 2025-05-03 · Supernus Pharmaceuticals, Inc. · $77.11 · Open Payments source 2025-05-03 · Supernus Pharmaceuticals, Inc. · $34.28 · Open Payments source 2025-06-09 · Supernus Pharmaceuticals, Inc. · $1,710.00 · Open Payments source 2025-09-17 · Supernus Pharmaceuticals, Inc. · $4,990.00 · Open Payments source 2025-12-04 · Supernus Pharmaceuticals, Inc. · $87.67 · Open Payments source 2025-12-04 · Supernus Pharmaceuticals, Inc. · $48.94 · Open Payments source 2025-12-04 · Supernus Pharmaceuticals, Inc. · $590.00 · Open Payments source 2025-12-04 · Supernus Pharmaceuticals, Inc. · $298.59 · Open Payments source 2025-12-04 · Supernus Pharmaceuticals, Inc. · $7,410.00 · Open Payments source 2025-12-04 · Supernus Pharmaceuticals, Inc. · $654.17 · Open Payments source 2025-12-05 · Supernus Pharmaceuticals, Inc. · $18.36 · Open Payments source 2025-12-05 · Supernus Pharmaceuticals, Inc. · $6.63 · Open Payments source 2025-12-05 · Supernus Pharmaceuticals, Inc. · $18.36 · Open Payments source 2025-12-05 · Supernus Pharmaceuticals, Inc. · $49.99 · Open Payments source 2025-12-05 · Supernus Pharmaceuticals, Inc. · $46.38 · Open Payments source 2025-12-05 · Supernus Pharmaceuticals, Inc. · $6.63 · Open Payments source
TONMYA Normalized: tonmya	Drug	Tonix Medicines, Inc.	$11,477.21	8	2025
Source payment records 2025-07-11 · Tonix Medicines, Inc. · $68.00 · Open Payments source 2025-07-12 · Tonix Medicines, Inc. · $95.00 · Open Payments source 2025-07-12 · Tonix Medicines, Inc. · $120.00 · Open Payments source 2025-07-12 · Tonix Medicines, Inc. · $541.67 · Open Payments source 2025-07-12 · Tonix Medicines, Inc. · $697.96 · Open Payments source 2025-07-12 · Tonix Medicines, Inc. · $503.36 · Open Payments source 2025-07-25 · Tonix Medicines, Inc. · $9,375.00 · Open Payments source 2025-07-25 · Tonix Medicines, Inc. · $76.22 · Open Payments source
Onyda XR Normalized: onyda xr	Drug	Tris Pharma Inc	$11,250.00	4	2025
Source payment records 2025-01-14 · Tris Pharma Inc · $750.00 · Open Payments source 2025-03-26 · Tris Pharma Inc · $750.00 · Open Payments source 2025-06-05 · Tris Pharma Inc · $9,000.00 · Open Payments source 2025-07-09 · Tris Pharma Inc · $750.00 · Open Payments source
AUSTEDO Normalized: austedo	Drug	Teva Pharmaceuticals USA, Inc.	$8,820.00	1	2025
Source payment records 2025-07-18 · Teva Pharmaceuticals USA, Inc. · $8,820.00 · Open Payments source
ERZOFRI EXTENDED-RELEASE Normalized: erzofri extended release	Drug	Luye Pharma (USA) Ltd.	$8,526.83	5	2025
Source payment records 2025-05-12 · Luye Pharma (USA) Ltd. · $2,100.00 · Open Payments source 2025-06-16 · Luye Pharma (USA) Ltd. · $3,900.00 · Open Payments source 2025-08-07 · Luye Pharma (USA) Ltd. · $2,400.00 · Open Payments source 2025-08-07 · Luye Pharma (USA) Ltd. · $60.55 · Open Payments source 2025-08-07 · Luye Pharma (USA) Ltd. · $66.28 · Open Payments source
BOTOX Normalized: botox	Biological	ABBVIE INC.	$5,400.00	1	2025
Source payment records 2025-10-07 · ABBVIE INC. · $5,400.00 · Open Payments source
REJOYN Normalized: rejoyn	Device	Otsuka Pharmaceutical Development & Commercialization, Inc.	$4,927.50	2	2025
Source payment records 2025-07-30 · Otsuka Pharmaceutical Development & Commercialization, Inc. · $175.50 · Open Payments source 2025-10-03 · Otsuka Pharmaceutical Development & Commercialization, Inc. · $4,752.00 · Open Payments source
XANAX Normalized: xanax	Drug	Oyster Point Pharma, Inc.	$2,724.00	1	2025
Source payment records 2025-02-15 · Oyster Point Pharma, Inc. · $2,724.00 · Open Payments source
Sunosi Normalized: sunosi	Drug	Axsome Therapeutics, Inc.	$2,475.00	1	2025
Source payment records 2025-09-17 · Axsome Therapeutics, Inc. · $2,475.00 · Open Payments source
LOREEV XR Normalized: loreev xr	Drug	Almatica Pharma LLC	$500.00	1	2025
Source payment records 2025-05-01 · Almatica Pharma LLC · $500.00 · Open Payments source
Xelstrym Normalized: xelstrym	Drug	Noven Therapeutics, LLC	$137.50	1	2025
Source payment records 2025-07-23 · Noven Therapeutics, LLC · $137.50 · Open Payments source
CYMBALTA Normalized: cymbalta	Drug	Eli Lilly and Company	$69.15	1	2025
Source payment records 2025-05-18 · Eli Lilly and Company · $69.15 · Open Payments source
ZYPREXA Normalized: zyprexa	Drug	Eli Lilly and Company	$69.15	1	2025
Source payment records 2025-05-18 · Eli Lilly and Company · $69.15 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$1,457,153.62 · 1315 records	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	ARISTADA, ARISTADA INITIO, AUSTEDO, AUSTEDO XR, Auvelity, BOTOX, CAPLYTA, COBENFY, CYMBALTA, ERZOFRI EXTENDED-RELEASE, FANAPT, INGREZZA, LOREEV XR, LYBALVI, Onyda XR, Qelbree, REJOYN, REXULTI, SPRAVATO, Sunosi, TONMYA, UZEDY, VRAYLAR, XANAX, Xelstrym, ZYPREXA	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error